<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn pub-type="epub" publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">40266</article-id><article-id pub-id-type="doi">10.7554/eLife.40266</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Advance</subject></subj-group><subj-group subj-group-type="heading"><subject>Developmental Biology</subject></subj-group></article-categories><title-group><article-title><italic>ppargc1a</italic> controls nephron segmentation during zebrafish embryonic kidney ontogeny</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-59688"><name><surname>Chambers</surname><given-names>Joseph M</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="con1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-117524"><name><surname>Poureetezadi</surname><given-names>Shahram Jevin</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="con2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-125672"><name><surname>Addiego</surname><given-names>Amanda</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="con3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-125673"><name><surname>Lahne</surname><given-names>Manuela</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="con4"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-50598"><name><surname>Wingert</surname><given-names>Rebecca A</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0003-3133-7549</contrib-id><email>rwingert@nd.edu</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="other" rid="fund1"/><xref ref-type="fn" rid="con5"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><label>1</label><institution content-type="dept">Department of Biological Sciences</institution><institution>University of Notre Dame</institution><addr-line><named-content content-type="city">Indiana</named-content></addr-line><country>United States</country></aff><aff id="aff2"><label>2</label><institution content-type="dept">Center for Stem Cells and Regenerative Medicine</institution><institution>University of Notre Dame</institution><addr-line><named-content content-type="city">Indiana</named-content></addr-line><country>United States</country></aff><aff id="aff3"><label>3</label><institution content-type="dept">Center for Zebrafish Research</institution><institution>University of Notre Dame</institution><addr-line><named-content content-type="city">Indiana</named-content></addr-line><country>United States</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="senior_editor"><name><surname>Morrison</surname><given-names>Sean J</given-names></name><role>Senior Editor</role><aff><institution>Howard Hughes Medical Institute, University of Texas Southwestern Medical Center</institution><country>United States</country></aff></contrib><contrib contrib-type="editor"><name><surname>Whitfield</surname><given-names>Tanya T</given-names></name><role>Reviewing Editor</role><aff><institution>University of Sheffield</institution><country>United Kingdom</country></aff></contrib></contrib-group><pub-date date-type="publication" publication-format="electronic"><day>26</day><month>11</month><year>2018</year></pub-date><pub-date pub-type="collection"><year>2018</year></pub-date><volume>7</volume><elocation-id>e40266</elocation-id><history><date date-type="received" iso-8601-date="2018-07-25"><day>25</day><month>07</month><year>2018</year></date><date date-type="accepted" iso-8601-date="2018-11-23"><day>23</day><month>11</month><year>2018</year></date></history><permissions><copyright-statement>© 2018, Chambers et al</copyright-statement><copyright-year>2018</copyright-year><copyright-holder>Chambers et al</copyright-holder><ali:free_to_read/><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><ali:license_ref>http://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-40266-v2.pdf"/><related-article ext-link-type="doi" id="ra1" related-article-type="article-reference" xlink:href="10.7554/eLife.17551"/><abstract><object-id pub-id-type="doi">10.7554/eLife.40266.001</object-id><p>Nephron segmentation involves a concert of genetic and molecular signals that are not fully understood. Through a chemical screen, we discovered that alteration of peroxisome proliferator-activated receptor (PPAR) signaling disrupts nephron segmentation in the zebrafish embryonic kidney (<xref ref-type="bibr" rid="bib61">Poureetezadi et al., 2016</xref>). Here, we show that the PPAR co-activator <italic>ppargc1a</italic> directs renal progenitor fate. <italic>ppargc1a</italic> mutants form a small distal late (DL) segment and an expanded proximal straight tubule (PST) segment. <italic>ppargc1a</italic> promotes DL fate by regulating the transcription factor <italic>tbx2b,</italic> and restricts expression of the transcription factor <italic>sim1a</italic> to inhibit PST fate. Interestingly, <italic>sim1a</italic> restricts <italic>ppargc1a</italic> expression to promote the PST, and PST development is fully restored in <italic>ppargc1a/sim1a</italic>-deficient embryos, suggesting Ppargc1a and Sim1a counterbalance each other in an antagonistic fashion to delineate the PST segment boundary during nephrogenesis. Taken together, our data reveal new roles for Ppargc1a during development, which have implications for understanding renal birth defects.</p></abstract><kwd-group kwd-group-type="author-keywords"><kwd>kidney</kwd><kwd>nephron</kwd><kwd>segmentation</kwd><kwd>pronephros</kwd><kwd>ppargc1a</kwd><kwd>sim1a</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Zebrafish</kwd></kwd-group><funding-group><award-group id="fund1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>R01DK100237</award-id><principal-award-recipient><name><surname>Wingert</surname><given-names>Rebecca A</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group><custom-meta-group><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>The transcriptional coactivator <italic>ppargc1a</italic> regulates the renal progenitor patterning to delineate boundary formation of differentiated segment populations during nephrogenesis.</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>The vertebrate kidney develops from the intermediate mesoderm and can have two or three stages depending on the organism, where amphibians and fish develop a pronephros and mesonephros, while others like birds and mammals form these structures and also generate a metanephros (<xref ref-type="bibr" rid="bib71">Saxén and Sariola, 1987</xref>). Roles of the kidney include regulation of osmolarity, fluid balance, and blood filtration. The kidney performs these tasks with functional units known as nephrons. Nephrons reabsorb or secrete precise amounts of essential molecules, ranging from amino acids to electrolytes, based on the dynamic physiological needs of the organism. Nephrons are divided into three main components: the filtration unit, a tubule, and a collecting duct (<xref ref-type="bibr" rid="bib67">Romagnani et al., 2013</xref>). Nephron tubules are further subdivided into unique epithelial segments that perform the specialized tasks of reabsorption or secretion of discrete cargos. Ongoing advances have shed light on a number of the molecular pathways and gene expression signatures associated with nephron segment formation in kidney forms across species (<xref ref-type="bibr" rid="bib14">Desgrange and Cereghini, 2015</xref>; <xref ref-type="bibr" rid="bib41">Lindström et al., 2015</xref>; <xref ref-type="bibr" rid="bib42">Lindström et al., 2018</xref>). Nevertheless, there are still many remaining questions about the genetic mechanisms that control segment fates and what specifies boundary formation between adjacent nephron segments.</p><p>The embryonic zebrafish pronephros is a tractable model to study the processes of nephron segmentation (<xref ref-type="bibr" rid="bib23">Gerlach and Wingert, 2013</xref>). Completely segmented at just 24 hours post fertilization (hpf), the pronephros is composed of two bilateral nephrons that possess a conserved order and arrangement of segment populations similar to other vertebrate nephrons (<xref ref-type="bibr" rid="bib78">Wingert and Davidson, 2008</xref>). These domains include two proximal and two distal tubule segments: the proximal convoluted tubule (PCT), proximal straight tubule (PST), distal early (DE), and distal late (DL) (<xref ref-type="bibr" rid="bib77">Wingert et al., 2007</xref>; <xref ref-type="bibr" rid="bib79">Wingert and Davidson, 2011</xref>). Additionally, genetic studies in zebrafish are readily performed using reverse approaches like genome editing, knockdown or various overexpression techniques, as well as forward approaches like chemical genetics. Recently, we reported the results from a novel small molecule screen using the zebrafish pronephros as a segmentation model, which included the discovery that modulators of peroxisome proliferator-activated receptor (PPAR) signaling altered nephron segmentation (<xref ref-type="bibr" rid="bib61">Poureetezadi et al., 2016</xref>). Until the present study, however, the functions of discrete PPAR signaling components during nephrogenesis have remained unknown.</p><p>PPAR family member peroxisome proliferator-activated receptor γ coactivator 1-alpha (Ppargc1a in zebrafish, PGC-1α in mammals) was discovered as a transcriptional coactivator for several nuclear hormone receptors such as PPAR alpha and gamma (PPARα, PPARγ), histone acetyltransferase steroid receptor coactivator 1 (SRC-1), and thyroid hormone receptor (<xref ref-type="bibr" rid="bib63">Puigserver et al., 1998</xref>; <xref ref-type="bibr" rid="bib64">Puigserver et al., 1999</xref>; <xref ref-type="bibr" rid="bib80">Wu et al., 1999</xref>). PGC-1α serves diverse functions in various contexts not only as a transcriptional coactivator, but also by interactions with chromatin remodeling factors and RNA processing complexes (<xref ref-type="bibr" rid="bib32">Knutti and Kralli, 2001</xref>; <xref ref-type="bibr" rid="bib65">Puigserver and Spiegelman, 2003</xref>). PGC-1α is well known to regulate mitochondrial biogenesis and cellular metabolism (<xref ref-type="bibr" rid="bib44">Lynch et al., 2018</xref>). Additionally, PGC-1α mediates the hepatocyte glucogenesis response to fasting (<xref ref-type="bibr" rid="bib29">Herzig et al., 2001</xref>; <xref ref-type="bibr" rid="bib81">Yoon et al., 2001</xref>), cardiac muscle and other slow-twitch muscle development (<xref ref-type="bibr" rid="bib39">Lin et al., 2002</xref>; <xref ref-type="bibr" rid="bib68">Russell et al., 2004</xref>), regulates angiogenesis (<xref ref-type="bibr" rid="bib2">Arany et al., 2008</xref>; <xref ref-type="bibr" rid="bib59">Patten et al., 2012</xref>; <xref ref-type="bibr" rid="bib69">Saint-Geniez et al., 2013</xref>) as well as intestinal and skeletal stem cell fate during aging (<xref ref-type="bibr" rid="bib13">D'Errico et al., 2011</xref>; <xref ref-type="bibr" rid="bib82">Yu et al., 2018</xref>).</p><p>There has been an increasing appreciation for the roles of PGC-1α in adult renal physiology and disease, related in part to high metabolic demands of the kidney and the fact that it is the second most mitochondrial abundant organ (<xref ref-type="bibr" rid="bib57">Pagliarini et al., 2008</xref>). PGC-1α is expressed in both the adult human kidney and the adult mouse kidney, specifically in the cortex and outer medulla (<xref ref-type="bibr" rid="bib73">Tran et al., 2011</xref>; <xref ref-type="bibr" rid="bib19">Fagerberg et al., 2014</xref>; <xref ref-type="bibr" rid="bib74">Tran et al., 2016</xref>; <xref ref-type="bibr" rid="bib6">Casemayou et al., 2017</xref>; <xref ref-type="bibr" rid="bib27">Han et al., 2017</xref>). In experimental murine models of acute and chronic kidney disease, PGC-1α activity has been shown to mediate renoprotection in tubular cells, and deleterious outcomes have been associated with lowered or absent PGC-1α levels in various kidney injury models (<xref ref-type="bibr" rid="bib44">Lynch et al., 2018</xref>). For example, in acute damage settings, PGC-1α expression is decreased and correlates with elevated fibrosis, whereas damage progression is attenuated when PGC-1α expression is induced (<xref ref-type="bibr" rid="bib73">Tran et al., 2011</xref>; <xref ref-type="bibr" rid="bib74">Tran et al., 2016</xref>; <xref ref-type="bibr" rid="bib27">Han et al., 2017</xref>). Interestingly, <italic>ppargc1a/PGC-1α</italic> expression has also been annotated in many tissues of developing zebrafish and mice, including the kidney, but their roles in organogenesis events at these locations have not yet been fully ascertained (<xref ref-type="bibr" rid="bib3">Bertrand et al., 2007</xref>; <xref ref-type="bibr" rid="bib72">Thisse and Thisse, 2008</xref>; <xref ref-type="bibr" rid="bib16">Diez-Roux et al., 2011</xref>; <xref ref-type="bibr" rid="bib20">Finger et al., 2017</xref>). Most pertinent to the current study, the purpose(s) for the expression of <italic>ppargc1a</italic> transcripts in nascent nephrons has not been explored up until this point.</p><p>Here, we report the discovery that <italic>ppargc1a</italic> has essential roles during nephron segmentation in the zebrafish embryonic kidney. Our studies reveal that the spatiotemporal localization of <italic>ppargc1a</italic> transcripts in the developing intermediate mesoderm is highly dynamic, where expression throughout the renal progenitors becomes progressively localized to subdomains of the distal nephron segment precursors. Through loss-of-function studies, we show that <italic>ppargc1a</italic> is necessary for proper formation of two nephron segments, the DL and PST. Furthermore, our genetic studies demonstrate that <italic>ppargc1a</italic> influences the regionalized expression domains of two essential transcription factors, <italic>T-box 2b</italic> (<italic>tbx2b</italic>) and <italic>SIM bHLH transcription factor 1a</italic> (<italic>sim1a</italic>), which specify the DL and PST segments, respectively. We discovered that the PST segment boundary is established by an antagonistic relationship between <italic>ppargc1a</italic> and <italic>sim1a</italic>. Further, our data reveal that this opposing interaction constitutes a fascinating layer of redundancy with respect to other events that orchestrate nephron segmentation. Taken together, these studies divulge novel mechanisms that define nephron segment boundaries in the embryonic renal mesoderm. Our findings have implications for understanding the basis of nephrogenesis in humans during normal development and congenital disorders affecting renal ontogeny as well.</p></sec><sec id="s2" sec-type="results"><title>Results</title><sec id="s2-1"><title>Bioactive small molecule chemical genetic screen reveals that alteration of PPAR signaling leads to changes in embryonic nephron segmentation</title><p>Chemical genetic screening is an efficient method used to employ the strengths of the zebrafish as a model organism to study a wide range of biological processes (<xref ref-type="bibr" rid="bib55">North et al., 2007</xref>; <xref ref-type="bibr" rid="bib22">Garnaas et al., 2012</xref>; <xref ref-type="bibr" rid="bib54">Nissim et al., 2014</xref>; <xref ref-type="bibr" rid="bib60">Poureetezadi et al., 2014</xref>). By applying different compounds to embryonic zebrafish, one is able to identify novel regulators in a high-throughput manner (<xref ref-type="bibr" rid="bib62">Poureetezadi and Wingert, 2016</xref>). In a chemical genetic screen of known bioactive compounds, we identified novel regulators of zebrafish pronephros segmentation using a riboprobe cocktail to survey alternating tubule populations (<xref ref-type="bibr" rid="bib61">Poureetezadi et al., 2016</xref>). One class of identified hits was compounds known to alter the activity of PPAR signaling (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1A,B</xref>). For example, bezafibrate, a PPAR alpha agonist, was found to reduce the length of the PCT and DE tubule segments, suggesting alterations in processes such as the patterning, growth or cell turnover in the developing nephron (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1A,B</xref>). Treatment with two PPAR gamma antagonists, BADGE and GW-9662, was associated with an increased DE; further, GW-9662 treatment was also scored as leading to a PCT segment increase (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1A,B</xref>). These results similarly suggested that alterations in PPAR signaling could modulate nephron segmentation.</p><p>To further explore the PPAR pathway result, we collected wild-type (WT) zebrafish embryos and then treated them with dimethyl sulfoxide (DMSO) vehicle control or 150 μM bezafibrate/DMSO from the 5 hpf stage (approximately 50% epiboly) until the 28 somite stage (ss) when the nephron is fully segmented. After removing the drug, embryos were fixed and whole mount <italic>in situ</italic> hybridization (WISH) was performed to specifically assess formation of each individual nephron tubule segment. For this, we utilized riboprobes to detect transcripts encoding: <italic>slc20a1a</italic>, to mark the PCT; <italic>trpm7</italic>, to mark the PST; <italic>slc12a1</italic>, to mark the DE; and <italic>slc12a3,</italic> to mark the DL (<xref ref-type="bibr" rid="bib77">Wingert et al., 2007</xref>). Embryos incubated with bezafibrate displayed a significantly increased length of the PST segment and a reduced DL segment compared to WT controls (<xref ref-type="fig" rid="fig1">Figure 1A,B</xref>). In contrast, there were no significant changes in the length of either the PCT or DE segments (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1C</xref>). This set of phenotypes was present in the majority of embryos (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1D</xref>). These findings indicated that emergence of the PST and DL segment populations can be modulated by changes in PPAR signaling, and suggested that some component(s) of the PPAR network might normally serve as renal regulators during nephrogenesis.</p><fig-group><fig id="fig1" position="float"><object-id pub-id-type="doi">10.7554/eLife.40266.002</object-id><label>Figure 1.</label><caption><title>PPAR agonist bezafibrate alters zebrafish pronephros segmentation, and the PPAR coactivator <italic>ppargc1a</italic> exhibits a dynamic expression pattern in renal progenitors.</title><p>(<bold>A</bold>) Double WISH at the 28 ss for the PST segment marker <italic>trpm7</italic> (top), and the DL segment marker <italic>slc12a3</italic> (bottom), with <italic>smyhc</italic> (red) to mark somites in DMSO control (left) and PPAR agonist, 150 μM Bezafibrate-treated (right) samples confirmed the initial hit from the chemical screen. Scale bar = 90 μm. (<bold>B</bold>) Absolute length measurements of the changes to pronephros segment lengths in bezafibrate treated (grey) and control samples (black). (<bold>C</bold>) Double WISH for <italic>ppargc1a</italic> (purple) expression at the 8 ss, 20 ss, and 28 ss with somites stained (red) (8 ss = <italic>deltaC</italic>, 20 ss and 28 ss = <italic>smyhc</italic>). (<bold>D</bold>) Double FISH at the 28 ss showing colocalization of <italic>ppargc1a</italic> (red) with <italic>slc12a1</italic> (distal early, left) and <italic>slc12a3</italic> (DL, right). Expression boundaries are indicated with blue (DE, left and DL, right) and white (<italic>ppargc1a</italic>) arrowheads. Scale bars = 35 μm. Data are represented as ±SD, significant by t test comparing the drug treatment to the DMSO vehicle control, n.s. = not significant, *** = p &lt; 0.001.</p></caption><graphic mime-subtype="x-tiff" mimetype="image" xlink:href="elife-40266-fig1-v2"/></fig><fig id="fig1s1" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.40266.003</object-id><label>Figure 1—figure supplement 1.</label><caption><title>Chemical genetics analysis of nephron development following exposure to PPAR pathway modulators.</title><p>Treatment with 150 μM bezafibrate does not alter two of the four segment boundaries at the 28 ss. (<bold>A</bold>) Table of hits from the initial chemical genetic screen that target the PPAR pathway (<bold>B</bold>) WISH for <italic>wt1b</italic> (podocytes), <italic>slc20a1a</italic> (PCT), and <italic>slc12a1</italic> (DE) in 28 ss zebrafish treated with chemicals targeting the PPAR pathway. (<bold>C</bold>) Treatment with 150 μM bezafibrate does not alter two of the four segment boundaries at the 28 ss. Double WISH showing no change in the boundary of <italic>slc20a1a</italic> or <italic>slc12a1</italic>, markers for PCT and DE, respectively, in DMSO control treated embryos and treated embryos. <italic>smyhc</italic> (red) marks the somites. Scale bars = 70 μm. (<bold>D</bold>) Penetrance graph showing the percent of phenotypes observed (green = increase, red = decrease, and black = WT) in control and treated samples. Data are represented as ±SD.</p></caption><graphic mime-subtype="x-tiff" mimetype="image" xlink:href="elife-40266-fig1-figsupp1-v2"/></fig><fig id="fig1s2" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.40266.004</object-id><label>Figure 1—figure supplement 2.</label><caption><title><italic>ppargc1a</italic> mRNA transcripts are expressed throughout the intermediate mesoderm before restricting to the distal nephron segments.</title><p>(<bold>A</bold>) Additional time points of <italic>ppargc1a</italic> (purple) mRNA expression illustrating the restricting domain from the 20 ss to the 28 ss. <italic>deltaC</italic> (12 ss) and <italic>smyhc</italic> (22–27 ss) were used to stain somites (red). <italic>ppargc1a</italic> mRNA expression at 30 hpf with a 20 X inset to show light proximal expression detectable at this stage. Scale bar = 90 μm. (<bold>B</bold>) Lateral (left) and flat-mounted dorsal (right) images of double WISH in 15 ss WT embryos for <italic>ppargc1a</italic> (purple) in and <italic>smyhc</italic> (red). The box indicates the approximate region of panel C. Scale bars = 110 μm (lateral) and 200 μm (dorsal flat-mount). (<bold>C</bold>) Double FISH in 15 ss WT embryos showing colocalization of <italic>ppargc1a</italic> (red, left) with <italic>pax2a</italic> (green, middle) and the images merged (right) with DAPI (blue). Scale bars = 100 μm.</p></caption><graphic mime-subtype="x-tiff" mimetype="image" xlink:href="elife-40266-fig1-figsupp2-v2"/></fig></fig-group></sec><sec id="s2-2"><title><italic>ppargc1a</italic> is dynamically expressed in the developing zebrafish embryonic kidney</title><p>Intrigued by these results, we next sought to identify whether the expression of any PPAR signaling components would situate them as possible candidates for involvement in nephron development. We surveyed online expression repositories and published literature and found that transcripts encoding <italic>ppargc1a</italic>/<italic>PGC-1α</italic> have been detected in nascent nephrons within the developing zebrafish pronephros and the mouse metanephros (<xref ref-type="bibr" rid="bib3">Bertrand et al., 2007</xref>; <xref ref-type="bibr" rid="bib72">Thisse and Thisse, 2008</xref>; <xref ref-type="bibr" rid="bib16">Diez-Roux et al., 2011</xref>; <xref ref-type="bibr" rid="bib1">Ai et al., 2017</xref>; <xref ref-type="bibr" rid="bib20">Finger et al., 2017</xref>). To further investigate this, we performed WISH on WT embryos and assessed the spatiotemporal patterns of <italic>ppargc1a</italic> expression throughout the stages of zebrafish pronephros ontogeny. <italic>ppargc1a</italic> transcripts were expressed in a pattern suggesting their presence in the entire populace of the developing intermediate mesoderm at the 8 ss, followed by a caudal restriction at the 20 ss before localizing to the distal segments at the 28 ss (<xref ref-type="fig" rid="fig1">Figure 1C</xref>, <xref ref-type="fig" rid="fig1s2">Figure 1—figure supplement 2</xref>). At the 30 hpf time point, weak expression levels of <italic>ppargc1a</italic> transcripts were detected in the proximal tubule as well (<xref ref-type="fig" rid="fig1s2">Figure 1—figure supplement 2A</xref>).</p><p>To confirm that <italic>ppargc1a</italic> was expressed in renal precursors, we employed double fluorescent WISH (FISH) and confocal imaging in WT embryos. At the 15 ss, <italic>ppargc1a</italic> transcripts were co-localized in the entire domain of cells that expressed transcripts encoding the intermediate mesoderm marker <italic>paired box 2a</italic> (<italic>pax2a</italic>) (<xref ref-type="fig" rid="fig1s2">Figure 1—figure supplement 2B,C</xref>) (<xref ref-type="bibr" rid="bib33">Krauss et al., 1991</xref>; <xref ref-type="bibr" rid="bib66">Püschel et al., 1992</xref>). By the 28 ss, <italic>ppargc1a</italic> transcripts were colocalized only in cells that expressed the distal segment markers <italic>slc12a1</italic> and <italic>slc12a3,</italic> indicating restriction to the DE and DL, respectively (<xref ref-type="fig" rid="fig1">Figure 1D</xref>). These data provide strong evidence that renal progenitors, followed by segment precursors and eventually differentiated distal segments, express <italic>ppargc1a</italic>. Based on the evidence that <italic>ppargc1a</italic> is dynamically expressed in the developing nephron, we hypothesized that it was involved in segment patterning.</p></sec><sec id="s2-3"><title><italic>ppargc1a</italic> is necessary for proper formation of proximal and distal segment boundaries</title><p>To define whether <italic>ppargc1a</italic> is essential for nephrogenesis, we designed several parallel strategies to perform loss of function studies. The <italic>ppargc1a</italic> locus is comprised of a series of 12 exons (<xref ref-type="fig" rid="fig2">Figure 2A</xref>), and these encode a peptide that shares high sequence similarity, particularly in key functional domains, to mouse and human PGC-1α (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1</xref>) (<xref ref-type="bibr" rid="bib65">Puigserver and Spiegelman, 2003</xref>). Four distinct locations of the <italic>ppargc1a</italic> sequence were targeted for experimental manipulation (<xref ref-type="fig" rid="fig2">Figure 2A</xref>, <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1</xref>) in order to disrupt transcriptional processing or translation. First, we obtained a <italic>ppargc1a</italic> genetic knockout line (<italic>ppargc1a<sup>sa13186</sup></italic>), which encodes a T-&gt;A substitution located in exon seven that results in a premature STOP codon and eliminates a series of essential peptide domains (<xref ref-type="fig" rid="fig2">Figure 2A</xref>) (ZIRC - Eugene, Oregon; <xref ref-type="bibr" rid="bib5">Busch-Nentwich et al., 2013</xref>). Sequencing confirmed the mutation and we developed a genotyping assay, which utilizes PCR amplification followed by NdeI restriction fragment length polymorphism digest analysis where the enzyme can cut the WT but not the mutant allele (<xref ref-type="fig" rid="fig2s2">Figure 2—figure supplement 2D</xref>). Second, we developed genetic models of <italic>ppargc1a</italic> deficiency using morpholinos (MOs). These included a translation blocking MO (MO1) (<xref ref-type="bibr" rid="bib28">Hanai et al., 2007</xref>; <xref ref-type="bibr" rid="bib3">Bertrand et al., 2007</xref>) and two splice blocking MOs (SB MO1, SB MO2) that we designed and subsequently validated through microinjection and RT-PCR studies in WT embryos (<xref ref-type="fig" rid="fig2">Figure 2A</xref>, <xref ref-type="fig" rid="fig2s3">Figure 2—figure supplements 3</xref> and <xref ref-type="fig" rid="fig2s4">4</xref>).</p><fig-group><fig id="fig2" position="float"><object-id pub-id-type="doi">10.7554/eLife.40266.005</object-id><label>Figure 2.</label><caption><title>Loss-of-function studies show <italic>ppargc1a</italic> is necessary for proper PST and DL formation.</title><p>(<bold>A</bold>) Exon map of zebrafish <italic>ppargc1a</italic> and the target sites (X) for morpholinos (MO) and the location of the <italic>ppargc1a<sup>sa13186</sup></italic> mutant allele. (<bold>B</bold>) WISH images of 28 ss <italic>ppargc1a<sup>sa13186</sup></italic> WT siblings (WT), <italic>ppargc1a<sup>sa13186-/-</sup></italic>, <italic>ppargc1a</italic> MO1 injected, and <italic>ppargc1a<sup>sa13186-/-</sup></italic> + <italic>ppargc1a</italic> cRNA illustrating the changes in PST (<italic>trpm7</italic>-purple, top) and DL (<italic>slc12a3</italic>-red, bottom) formation in the <italic>ppargc1a<sup>sa13186-/-</sup></italic> and <italic>ppargc1a</italic> morphants, and the subsequent rescue when <italic>ppargc1a</italic> cRNA was added to the <italic>ppargc1a<sup>sa13186-/-</sup></italic>. Scale bars = 100 μm. Absolute length measurements of the PST (<bold>C</bold>), and DL (<bold>D</bold>) segments. (<bold>E</bold>) <italic>ppargc1a</italic> expression in DMSO control (top) and 150 μM bezafibrate-treated (bottom) zebrafish at the 28 ss following vehicle or vehicle/drug addition at the 5 hpf stage. Scale bars = 65 μm. (<bold>F</bold>) Absolute length measurements of the <italic>ppargc1a</italic> expression domain at 28 ss in DMSO control and bezafibrate-treated embryos from panel E. (<bold>G</bold>) qRT-PCR results showing <italic>ppargc1a</italic> RNA expression levels in bezafibrate-treated samples compared to DMSO controls. Data are represented as ±SD, significant by t test, n.s. = not significant, ** = p &lt; 0.01, *** = p &lt; 0.001.</p></caption><graphic mime-subtype="x-tiff" mimetype="image" xlink:href="elife-40266-fig2-v2"/></fig><fig id="fig2s1" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.40266.006</object-id><label>Figure 2—figure supplement 1.</label><caption><title><italic>ppargc1a</italic> is conserved across vertebrate species.</title><p>Sequence alignment illustration of zebrafish (top), mouse (middle), and human <italic>Ppargc1a</italic> amino acids. Black background indicates conservation among species. Conserved protein functional domains are indicated with color labeling and lines to demarcate their locales.</p></caption><graphic mime-subtype="x-tiff" mimetype="image" xlink:href="elife-40266-fig2-figsupp1-v2"/></fig><fig id="fig2s2" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.40266.007</object-id><label>Figure 2—figure supplement 2.</label><caption><title><italic>ppargc1a</italic> loss of function does not affect PCT or DE segment development.</title><p>(<bold>A</bold>) Double or single WISH for the PCT (<italic>slc20a1a</italic>) and the DE (<italic>slc12a1</italic>) for WT, <italic>ppargc1a</italic> MO1 injected, and <italic>ppargc1a<sup>sa13186-/-</sup></italic> do not indicate a change in the domain length of either segment marker at the 28 ss. Scale bar = 70 μm. Absolute length measurements for the PCT (<bold>B</bold>) and DE (<bold>C</bold>). Data are represented as ±SD, significant by t test, n.s. = not significant. (<bold>D</bold>) Schematic showing the details of a genotyping assay performed to identify <italic>ppargc1a<sup>sa13186-/-</sup></italic>.</p></caption><graphic mime-subtype="x-tiff" mimetype="image" xlink:href="elife-40266-fig2-figsupp2-v2"/></fig><fig id="fig2s3" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.40266.008</object-id><label>Figure 2—figure supplement 3.</label><caption><title>Loss of function via a <italic>ppargc1a</italic> splice blocking MO recapitulates the decreased DL phenotype seen in other loss of function tests.</title><p>(<bold>A</bold>) WISH for <italic>slc12a3</italic> (DL) in 28 ss WT (top) and splice blocking (SB) MO1 (bottom) with the graph (<bold>B</bold>) showing absolute length measurements of representative samples. Scale bar = 100 μm. (<bold>C</bold>) RT-PCR analysis revealed disrupted splicing of <italic>ppargc1a</italic> at the target site specified on the exon map schematic. Data are represented as ±SD, significant by t test, *** = p &lt; 0.001.</p></caption><graphic mime-subtype="x-tiff" mimetype="image" xlink:href="elife-40266-fig2-figsupp3-v2"/></fig><fig id="fig2s4" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.40266.009</object-id><label>Figure 2—figure supplement 4.</label><caption><title>Loss of function via a <italic>ppargc1a</italic> splice blockingMO recapitulates the decreased DL phenotype seen in other loss of function tests.</title><p>(<bold>A</bold>) WISH for <italic>slc12a3</italic> (DL) in 28 ss WT (top) and splice blocking (SB) MO2 (bottom) with the graph (<bold>B</bold>) showing absolute length measurements of representative samples. Scale bar = 100 μm. (<bold>C</bold>) RT-PCR analysis revealed disrupted splicing of <italic>ppargc1a</italic> at the target site specified on the exon map schematic. Data are represented as ±SD, significant by t test, *** = p &lt; 0.001.</p></caption><graphic mime-subtype="x-tiff" mimetype="image" xlink:href="elife-40266-fig2-figsupp4-v2"/></fig><fig id="fig2s5" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.40266.010</object-id><label>Figure 2—figure supplement 5.</label><caption><title>The time of bezafibrate addition causes differential effects on <italic>ppargc1a</italic> domain length, and the effect of bezafibrate on DL development is not rescued by <italic>ppargc1a</italic> RNA overexpression.</title><p>(<bold>A</bold>) Various time points for chemical addition in DMSO control (left) and 150 μM bezafibrate (right) treated 28 ss zebrafish after WISH for <italic>ppargc1a</italic>. Scale bars = 60 μm. (<bold>B</bold>) The absolute measurement of <italic>ppargc1a</italic> domain length in DMSO control compared to 150 μM bezafibrate treated at the various time points of addition. Note: 5 hpf time of addition data is depicted here for statistical comparison in addition to <xref ref-type="fig" rid="fig2">Figure 2F</xref>. (<bold>C</bold>) WISH for <italic>ppargc1a</italic> expression at 15 ss in DMSO control and 150 μM bezafibrate treated (5 hpf - 15 ss) zebrafish. Scale bar = 100 μm. (<bold>D</bold>) WISH for <italic>slc12a3</italic> (DL) in DMSO control and 150 μM bezafibrate treated (top) and DMSO control +<italic>ppargc1</italic> a cRNA and 150 μM bezafibrate treated +<italic>ppargc1</italic> a cRNA (bottom). (<bold>E</bold>) Absolute measurements of <italic>slc12a3</italic> domain length. Scale bars = 100 μm. Data are represented as ±SD, significant by ANOVA (<bold>B</bold>) or t test (<bold>E</bold>), n.s. = not significant, * = p &lt; 0.05, *** = p &lt; 0.001.</p></caption><graphic mime-subtype="x-tiff" mimetype="image" xlink:href="elife-40266-fig2-figsupp5-v2"/></fig><fig id="fig2s6" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.40266.011</object-id><label>Figure 2—figure supplement 6.</label><caption><title>Pronephros and body length measurements indicate no significant change in any treatment group compared to WT.</title><p>(<bold>A</bold>) WISH for tubule marker <italic>cdh17</italic> in 28 ss WT, <italic>ppargc1a</italic> MO1, <italic>ppargc1a<sup>sa13186-</sup></italic><sup>/-</sup>, DMSO control, and 150 μM bezafibrate-treated zebrafish. Scale bar = 75 μm. (<bold>B</bold>) Absolute length measurements of <italic>cdh17</italic> in the various treatment groups. (<bold>C</bold>) Body length absolute measurements from the head/yolk sac boundary to the tip of the <italic>cdh17</italic> stain (approximate collecting duct area). Data are represented as ±SD, and comparisons between all groups were not significant by t test.</p></caption><graphic mime-subtype="x-tiff" mimetype="image" xlink:href="elife-40266-fig2-figsupp6-v2"/></fig></fig-group><p>The <italic>ppargc1a</italic> mutant and knockdown reagents were then utilized to evaluate nephron segment development. Embryos were collected from pairwise matings of <italic>ppargc1a<sup>sa13186+/-</sup></italic> adult carriers and fixed at the 28 ss. For the knockdowns, WT embryos were microinjected at the one-cell stage with either MO1, SB MO1 or SB MO2 and similarly fixed at the 28 ss. WISH was completed on the <italic>ppargc1a-</italic>deficient embryo cohorts using segment-specific riboprobes to assess formation of the PCT, PST, DE and DL. Both <italic>ppargc1a<sup>sa13186-/-</sup></italic>mutants and knockdown embryos had a significantly expanded PST segment and a significantly decreased DL segment (<xref ref-type="fig" rid="fig2">Figure 2B–D</xref>, <xref ref-type="fig" rid="fig2s3">Figure 2—figure supplements 3</xref> and <xref ref-type="fig" rid="fig2s4">4</xref>). In contrast, there were no significant changes in PCT or DE segment formation (<xref ref-type="fig" rid="fig2s2">Figure 2—figure supplement 2A–C</xref>).</p><p>To further verify the specificity of the phenotypes, we performed rescue studies in <italic>ppargc1a</italic> mutant embryos. Full-length <italic>ppargc1a</italic> capped mRNA (cRNA) was synthesized in vitro, purified and microinjected at the one-cell stage into clutches obtained from pairwise matings of <italic>ppargc1a<sup>sa13186</sup></italic><sup>+/-</sup> adults. Segmentation was assessed by WISH at the 28 ss to evaluate the development of the PST and DL segments. <italic>ppargc1a</italic> cRNA was sufficient to rescue PST and DL segment length in <italic>ppargc1a<sup>sa13186</sup></italic><sup>-/-</sup> mutant embryos (<xref ref-type="fig" rid="fig2">Figure 2B–D</xref>). This result confirmed that the nephron phenotypes observed in this mutant model are caused by specific disruption of <italic>ppargc1a</italic> and exclude the possibility of other underlying genetic alterations.</p><p>Next, we explored whether there was a connection between the outcomes of bezafibrate treatment and <italic>ppargc1a</italic> loss of function during nephron segmentation. Previous publications have reported that PPAR agonists, including bezafibrate, can cause an increase or decrease of <italic>ppargc1a/PGC1a</italic> expression in cells and tissues in a context-dependent manner (<xref ref-type="bibr" rid="bib58">Pardo et al., 2011</xref>; <xref ref-type="bibr" rid="bib38">Liao et al., 2010</xref>; <xref ref-type="bibr" rid="bib70">Sanoudou et al., 2010</xref>; <xref ref-type="bibr" rid="bib25">Goto et al., 2017</xref>; <xref ref-type="bibr" rid="bib75">Wang and Moraes, 2011</xref>). Since bezafibrate treatment and <italic>ppargc1a</italic> deficiency caused matching segment phenotypes, we hypothesized that bezafibrate decreased <italic>ppargc1a</italic> expression in renal progenitors. To test this, WT embryos were treated with either vehicle control or 150 μM bezafibrate/DMSO beginning at different developmental times (4 hpf, 5 hpf, 6 hpf, 8 hpf, 9 hpf, 10 hpf, 5 ss and 10 ss), incubated until the 28 ss, and then WISH was performed. Compared to WT controls, bezafibrate treatment resulted in a significant decrease in the expression domain of <italic>ppargc1a</italic> in the pronephros when the drug was added between 4 and 9 hpf (<xref ref-type="fig" rid="fig2">Figure 2E,F</xref>, <xref ref-type="fig" rid="fig2s5">Figure 2—figure supplement 5A,B</xref>). Next, we explored whether the <italic>ppargc1a</italic> expression domain was altered at the 15 ss when it is normally expressed in the <italic>pax2a<sup>+</sup></italic> renal progenitor domain. Embryos were treated with DMSO vehicle or 150 μM bezafibrate/DMSO at the 5 hpf stage, and then fixed at 15 ss for WISH. Interestingly, the <italic>ppargc1a</italic> expression domain in renal progenitors at 15 ss was not altered by the bezafibrate treatment (<xref ref-type="fig" rid="fig2s5">Figure 2—figure supplement 5C</xref>). We also performed qRT-PCR on pools of 28 ss embryos treated with DMSO vehicle or 150 μM bezafibrate/DMSO at the 5 hpf stage to quantify <italic>ppargc1a</italic> expression levels. There was no significant difference in total <italic>ppargc1a</italic> mRNA levels between WT and bezafibrate-treated embryos (<xref ref-type="fig" rid="fig2">Figure 2G</xref>). Furthermore, we found that <italic>ppargc1a</italic> RNA overexpression was not sufficient to rescue DL development at the 28 ss in embryos treated with bezafibrate at the 5 hpf stage (<xref ref-type="fig" rid="fig2s5">Figure 2—figure supplement 5D,E</xref>). Additionally, we assessed the overall morphology as well as pronephros formation in 28 ss embryos treated with bezafibrate or vehicle control at the 5 hpf, as well as wild-type and <italic>ppargc1a</italic>-deficient embryos (<xref ref-type="fig" rid="fig2s6">Figure 2—figure supplement 6</xref>). Analysis of body length and pronephros length, the latter through WISH to detect expression of the pan-tubule and duct marker <italic>cdh17</italic>, showed no statistically significant differences between the groups (<xref ref-type="fig" rid="fig2s6">Figure 2—figure supplement 6</xref>). Taken together, these results are consistent with the notion that the <italic>ppargc1a</italic> expression domain is reduced in bezafibrate-treated embryos because the DL is reduced, and not specifically due to the loss of <italic>ppargc1a</italic> activity.</p></sec><sec id="s2-4"><title>Loss of <italic>ppargc1a</italic> does not change cellular turnover in the developing nephrons</title><p>Segmentation of the renal progenitors in the intermediate mesoderm occurs from the early somitogenesis stages through to the 28 ss based on the detection of molecularly distinct regions that emerge and then show dynamic alterations over this developmental time period, all while the renal progenitors are also undergoing a mesenchymal to epithelial transition (<xref ref-type="bibr" rid="bib77">Wingert et al., 2007</xref>; <xref ref-type="bibr" rid="bib79">Wingert and Davidson, 2011</xref>; <xref ref-type="bibr" rid="bib37">Li et al., 2014</xref>; <xref ref-type="bibr" rid="bib24">Gerlach and Wingert, 2014</xref>; <xref ref-type="bibr" rid="bib51">McKee et al., 2014</xref>; <xref ref-type="bibr" rid="bib35">Kroeger and Wingert, 2014</xref>; <xref ref-type="bibr" rid="bib11">Cheng and Wingert, 2015</xref>; <xref ref-type="bibr" rid="bib47">Marra and Wingert, 2016</xref>; <xref ref-type="bibr" rid="bib17">Drummond et al., 2017</xref>; <xref ref-type="bibr" rid="bib61">Poureetezadi et al., 2016</xref>). The proliferation and caudal migration of renal precursors has also been reported to impact pronephros segment size (<xref ref-type="bibr" rid="bib53">Naylor et al., 2016</xref>). To this end, we wanted to determine when the loss of <italic>ppargc1a</italic> first presented significant changes to the emerging segment domains, and to address if these changes were coincident with alterations in cellular dynamics in the nephron field.</p><p>A series of WISH studies were performed with PST and DL markers to compare these emerging segment populations in WT controls and <italic>ppargc1a-</italic>deficient embryos (<xref ref-type="fig" rid="fig3">Figure 3</xref>). We found that the earliest time point of divergence between WT and <italic>ppargc1a-</italic>deficient embryos occurred at the 20 ss, when there was a distinction in the expression domain of both the PST marker <italic>trpm7</italic> and DL marker <italic>slc12a3</italic> (<xref ref-type="fig" rid="fig3">Figure 3A–D</xref>, <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1</xref>). <italic>ppargc1a-</italic>deficient embryos displayed a significant increase in the emerging PST length and a significant decrease in the emerging DL length (<xref ref-type="fig" rid="fig3">Figure 3A–D</xref>). These changes correlate with the result that <italic>ppargc1a</italic> mutants and morphants exhibit a longer PST and shortened DL when segmentation is completed (<xref ref-type="fig" rid="fig2">Figure 2</xref>).</p><fig-group><fig id="fig3" position="float"><object-id pub-id-type="doi">10.7554/eLife.40266.012</object-id><label>Figure 3.</label><caption><title>Loss of <italic>ppargc1a</italic> does result in segment changes at the 20 ss but no change in cellular turnover is observed.</title><p>(<bold>A</bold>) WISH at the 20 ss for <italic>trpm7</italic> (left) and (<bold>B</bold>) <italic>slc12a3</italic> (right) in WT (top) and <italic>ppargc1a</italic> MO (bottom). Blue arrowheads indicate <italic>trpm7</italic> expression in the developing pronephros. Scale bar = 100 μm. The representative graphs showing absolute length measurements of <italic>trpm7</italic> (<bold>C</bold>) and <italic>slc12a3</italic> (<bold>D</bold>). (<bold>E</bold>) FISH/IHC for <italic>trpm7</italic> (red) and anti-Caspase-3 (green) with DAPI (blue) in WT (top) and <italic>ppargc1a</italic> MO1 (bottom). (<bold>F</bold>) FISH/IHC for <italic>trpm7</italic> (red) and anti-phospho-Histone H3 (green) in WT (top) and <italic>ppargc1a</italic> MO1 (bottom). (<bold>G</bold>) FISH/IHC for <italic>slc12a3</italic> (red) and anti-Caspase-3 (green) with DAPI (blue) in WT (top) and <italic>ppargc1a</italic> MO1 (bottom). (<bold>H</bold>) FISH/IHC for <italic>slc12a3</italic> (red) and anti-phospho-Histone H3 (green) with DAPI (blue) in WT (top) and <italic>ppargc1a</italic> MO1 (bottom). (<bold>I</bold>) The number of <italic>trpm7</italic>/Caspase-3 or <italic>trpm7</italic>/pH3 double-positive cells is depicted. (<bold>J</bold>) The number of <italic>slc12a3</italic>/Caspase-3 or <italic>slc12a3</italic>/pH3 double positive cells is depicted. (WT quantifications = black bars, <italic>ppargc1a-</italic>deficient quantifications = white bars.) Data are represented as ±SD, significant by t test, n.s. = not significant, *** = p &lt; 0.001.</p></caption><graphic mime-subtype="x-tiff" mimetype="image" xlink:href="elife-40266-fig3-v2"/></fig><fig id="fig3s1" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.40266.013</object-id><label>Figure 3—figure supplement 1.</label><caption><title>Decreased DL phenotypes are evident at the 25 ss and 27 ss in <italic>ppargc1a-</italic>deficient embryos.</title><p>(<bold>A</bold>) Double WISH for <italic>slc12a3</italic> (purple) and <italic>smyhc</italic> (red) in WT and <italic>ppargc1a</italic> MO1 injected zebrafish. Scale bars = 100 μm. (<bold>B</bold>) Graph indicating the <italic>slc12a3</italic> domain length in relation to age (in ss) in WT (black) and MO1 injected (white).</p></caption><graphic mime-subtype="x-tiff" mimetype="image" xlink:href="elife-40266-fig3-figsupp1-v2"/></fig><fig id="fig3s2" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.40266.014</object-id><label>Figure 3—figure supplement 2.</label><caption><title>Confocal image split channels of <italic>trpm7</italic> and anti-Caspase-3 in WT and <italic>ppargc1a</italic> deficient 20 ss zebrafish.</title><p><italic>trpm7</italic> (red) with DAPI (blue) on bottom, anti-Caspase-3 (green) with DAPI (blue) middle, and merge on top. Scale bar = 30 μm.</p></caption><graphic mime-subtype="x-tiff" mimetype="image" xlink:href="elife-40266-fig3-figsupp2-v2"/></fig><fig id="fig3s3" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.40266.015</object-id><label>Figure 3—figure supplement 3.</label><caption><title>Confocal image split channels of <italic>trpm7</italic> and anti-pH3 in WT and <italic>ppargc1a</italic> deficient 20 ss zebrafish.</title><p><italic>trpm7</italic> (red) with DAPI (blue) on bottom, anti-pH3 (green) with DAPI (blue) middle, and merge on top. Scale bar = 30 μm.</p></caption><graphic mime-subtype="x-tiff" mimetype="image" xlink:href="elife-40266-fig3-figsupp3-v2"/></fig><fig id="fig3s4" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.40266.016</object-id><label>Figure 3—figure supplement 4.</label><caption><title>Confocal image split channels of <italic>slc12a3</italic> and anti-Caspase-3 in WT and <italic>ppargc1a-</italic>deficient 20 ss zebrafish.</title><p><italic>slc12a3</italic> (red) with DAPI (blue) on bottom, anti-Caspase-3 (green) with DAPI (blue) middle, and merge on top. Scale bar = 30 μm.</p></caption><graphic mime-subtype="x-tiff" mimetype="image" xlink:href="elife-40266-fig3-figsupp4-v2"/></fig><fig id="fig3s5" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.40266.017</object-id><label>Figure 3—figure supplement 5.</label><caption><title>Confocal image split channels of <italic>slc12a3</italic> and anti-pH3 in WT and <italic>ppargc1a-</italic>deficient 20 ss zebrafish.</title><p><italic>slc12a3</italic> (red) with DAPI (blue) on bottom, anti-pH3 (green) with DAPI (blue) middle, and merge on top. Scale bar = 30 μm.</p></caption><graphic mime-subtype="x-tiff" mimetype="image" xlink:href="elife-40266-fig3-figsupp5-v2"/></fig></fig-group><p>At this pivotal 20 ss time point, we then sought to identify whether either of these changes were associated with regional fluctuations in cell birth or death. To assess this, we combined FISH with whole mount immunohistochemistry and confocal imaging to assess the PST and DL. WT control and <italic>ppargc1a-</italic>deficient embryos were fixed at the 20 ss and nephron cells were detected based on <italic>trpm7</italic> (PST) or <italic>slc12a3</italic> (DL) transcripts in combination with either anti-Caspase-3 to detect cell death or anti-phospho-Histone H3 (anti-pH3) to label proliferating cells (<xref ref-type="bibr" rid="bib34">Kroeger et al., 2017</xref>). The results showed that there was no significant difference between WT and <italic>ppargc1a-</italic>deficient embryos in the number of <italic>trpm7<sup>+</sup></italic>/anti-Caspase-3<sup>+</sup> cells (<xref ref-type="fig" rid="fig3">Figure 3E,I</xref>, <xref ref-type="fig" rid="fig3s2">Figure 3—figure supplement 2</xref>) or <italic>slc12a3<sup>+</sup></italic>/anti-Caspase-3<sup>+</sup> cells (<xref ref-type="fig" rid="fig3">Figure 3G,J</xref>, <xref ref-type="fig" rid="fig3s4">Figure 3—figure supplement 4</xref>). Quantification of <italic>trpm7<sup>+</sup></italic>/pH3<sup>+</sup> cell number (<xref ref-type="fig" rid="fig3">Figure 3F,I</xref>, <xref ref-type="fig" rid="fig3s3">Figure 3—figure supplement 3</xref>) and <italic>slc12a3<sup>+</sup></italic>/pH3<sup>+</sup> cell number (<xref ref-type="fig" rid="fig3">Figure 3H,J</xref>, <xref ref-type="fig" rid="fig3s5">Figure 3—figure supplement 5</xref>) also showed that there was no statistically significant difference between WT and <italic>ppargc1a-</italic>deficient groups. The results from these experiments suggest that there are no significant changes in cellular turnover driving the PST and DL segment boundary changes that occur in <italic>ppargc1a-</italic>deficient embryos.</p></sec><sec id="s2-5"><title><italic>ppargc1a</italic> promotes DL segment formation by positively regulating the expression domain of the <italic>tbx2b</italic> transcription factor in nephron precursors</title><p>To gain insight into how <italic>ppargc1a</italic> influences nephron segmentation, we next explored its relationship with the T-box transcription factor <italic>tbx2b,</italic> which was recently shown to be essential for DL formation (<xref ref-type="bibr" rid="bib17">Drummond et al., 2017</xref>). Transcripts encoding <italic>tbx2b</italic> are highly expressed in the distal regions of the zebrafish pronephros, and loss of <italic>tbx2b</italic> results in a significantly decreased DL segment size (<xref ref-type="bibr" rid="bib17">Drummond et al., 2017</xref>). To test the relationship between <italic>ppargc1a</italic> and <italic>tbx2b</italic>, WISH was performed on <italic>ppargc1a</italic> deficient embryos to assess <italic>tbx2b</italic> expression. Compared to WT controls, the <italic>tbx2b</italic> expression domain in the nephron was significantly reduced in <italic>ppargc1a<sup>sa13186-/-</sup></italic> mutants (<xref ref-type="fig" rid="fig4">Figure 4A,B</xref>) as well as <italic>ppargc1a</italic> morphants (data not shown). These results led us to hypothesize that loss of <italic>tbx2b</italic> expression underlies the decreased DL segment domain when Ppargc1a activity is compromised. When the reciprocal experiment was performed in <italic>tbx2b-</italic>deficient embryos (<xref ref-type="bibr" rid="bib17">Drummond et al., 2017</xref>; <xref ref-type="bibr" rid="bib26">Gross and Dowling, 2005</xref>), we detected no change in <italic>ppargc1a</italic> expression (<xref ref-type="fig" rid="fig4">Figure 4C,D</xref>), consistent with the notion that <italic>ppargc1a</italic> is upstream of <italic>tbx2b</italic>.</p><fig id="fig4" position="float"><object-id pub-id-type="doi">10.7554/eLife.40266.018</object-id><label>Figure 4.</label><caption><title><italic>ppargc1a</italic> acts upstream of <italic>tbx2b</italic> to form the DL segment.</title><p>(<bold>A</bold>) WISH for <italic>tbx2b</italic> (purple) expression in 28 ss WT and <italic>ppargc1a<sup>sa13186-/-</sup></italic>zebrafish. Scale bars = 75 μm. (<bold>B</bold>) Absolute length measurements of <italic>tbx2b</italic> mRNA expression domains in WT and <italic>ppargc1a<sup>sa13186-/-</sup></italic> zebrafish. (<bold>C</bold>) <italic>ppargc1a</italic> expression in WT and <italic>tbx2b</italic> MO injected 28 ss zebrafish. Scale bars = 65 μm. (<bold>D</bold>) Absolute length measurements of <italic>ppargc1a</italic> expression domain in WT and <italic>tbx2b</italic> MO injected zebrafish. (<bold>E</bold>) WISH at 28 ss for <italic>slc12a3</italic> (purple) in WT, <italic>ppargc1a<sup>sa13186-/-</sup></italic>, and <italic>ppargc1a<sup>sa13186-/-</sup></italic> injected with <italic>tbx2b</italic> cRNA. Scale bars = 75 μm. (<bold>F</bold>) Absolute length measurements of <italic>slc12a3</italic> mRNA expression domains in WT, <italic>ppargc1a<sup>sa13186-/-</sup></italic>, and <italic>ppargc1a<sup>sa13186-/-</sup></italic> + <italic>tbx2b</italic> cRNA. Data are represented as ±SD, significant by t test, n.s. = not significant, ** = p &lt; 0.01, and *** = p &lt; 0.001.</p></caption><graphic mime-subtype="x-tiff" mimetype="image" xlink:href="elife-40266-fig4-v2"/></fig><p>To test this further, we examined whether overexpression of <italic>tbx2b</italic> was sufficient to rescue DL development in <italic>ppargc1a</italic> mutants. <italic>tbx2b</italic> cRNA was injected at the one-cell stage into clutches obtained from matings of <italic>ppargc1a<sup>sa13186+/-</sup></italic> adults, and segmentation was assessed at the 28 ss by WISH using our DL-specific riboprobe followed by genotype analysis (<xref ref-type="fig" rid="fig4">Figure 4E</xref>). While <italic>ppargc1a<sup>sa13186-/-</sup></italic> mutants displayed the hallmark short DL segment, there was no significant difference in DL length between WT controls and <italic>ppargc1a<sup>sa13186-/-</sup></italic> mutants that received <italic>tbx2b</italic> cRNA, indicating that <italic>tbx2b</italic> provision had rescued DL segment development (<xref ref-type="fig" rid="fig4">Figure 4E,F</xref>). Taken together, these results indicate that Ppargc1a regulates <italic>tbx2b</italic>, either directly or indirectly, to control formation of the DL segment.</p></sec><sec id="s2-6"><title><italic>ppargc1a</italic> regulates PST boundary formation through a reciprocally antagonistic relationship with the <italic>sim1a</italic> transcription factor</title><p>During zebrafish embryonic nephron segmentation, <italic>sim1a</italic> is necessary and sufficient for formation of the PST segment as well as the Corpuscle of Stannius (CS), the latter being an endocrine gland in teleost fish which arises from the intermediate mesoderm, where CS precursors are intermingled with distal segment precursors (<xref ref-type="bibr" rid="bib10">Cheng et al., 2015</xref>). Thus, we sought to delineate the relationship between <italic>ppargc1a</italic> and <italic>sim1a</italic>. To do this, we examined <italic>ppargc1a</italic> expression in <italic>sim1a-</italic>deficient embryos in which transcript splicing is abrogated through morpholino knockdown (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1</xref>) (<xref ref-type="bibr" rid="bib43">Löhr et al., 2009</xref>; <xref ref-type="bibr" rid="bib11">Cheng and Wingert, 2015</xref>). Interestingly, we found that the domain of <italic>ppargc1a</italic> expression in renal progenitors was significantly increased in length in the <italic>sim1a-</italic>deficient embryos compared to WT controls (<xref ref-type="fig" rid="fig5">Figure 5A,D</xref>). This result suggested <italic>sim1a</italic> was possibly upstream of <italic>ppargc1a</italic>.</p><fig-group><fig id="fig5" position="float"><object-id pub-id-type="doi">10.7554/eLife.40266.019</object-id><label>Figure 5.</label><caption><title><italic>ppargc1a</italic> and <italic>sim1a</italic> have a reciprocal antagonistic relationship that is necessary to negotiate the PST segment boundary.</title><p>(<bold>A</bold>) WISH for <italic>ppargc1a</italic> (purple) expression at 28 ss in WT, <italic>sim1a</italic> MO, and <italic>sim1a</italic> cRNA injected zebrafish. The green and red dashed lines indicate the beginning and the end of WT expression, respectively, the expansion of the <italic>ppargc1a</italic> domain in <italic>sim1a</italic> MO is denoted with asterisks, and the reduction in the <italic>ppargc1a</italic> domain in <italic>sim1a</italic> cRNA injected is denoted with arrowheads. Scale bars = 60 μm. (<bold>B</bold>) WISH for <italic>sim1a</italic> (purple) and <italic>smyhc</italic> (red) in 20 ss WT, <italic>ppargc1a<sup>sa13186-/-</sup></italic>, and <italic>ppargc1a</italic> cRNA injected zebrafish. Arrows and the dashed green line represent the beginning of the <italic>sim1a</italic> domain expression, the red dashed line indicate the end of the WT <italic>sim1a</italic> expression domain to illustrate the expansion of the segment boundary in <italic>ppargc1a<sup>sa13186-/-</sup></italic> is denoted with asterisks, and the reduction of the <italic>sim1a</italic> domain in <italic>ppargc1a</italic> cRNA injected is denoted with arrowheads. Scale bar = 40 μm. (<bold>C</bold>) WISH for <italic>trpm7</italic> at 28 ss in WT, <italic>sim1a</italic> cRNA, and <italic>ppargc1a</italic> cRNA injected zebrafish. Scale bar = 50 μm (<bold>D</bold>) Absolute length measurements of the <italic>ppargc1a</italic> domain in 28 ss in WT, <italic>sim1a</italic> MO injected, and <italic>sim1a</italic> cRNA injected zebrafish. (<bold>E</bold>) Absolute length measurements of the 20 ss <italic>sim1a</italic> domain in WT, <italic>ppargc1a<sup>sa13186-</sup></italic><sup>/-</sup>, and <italic>ppargc1a</italic> cRNA injected zebrafish. (<bold>F</bold>) Absolute length measurements of the <italic>trpm7</italic> domain in the 28 ss WT, <italic>sim1a</italic> cRNA injected, and <italic>ppargc1a</italic> cRNA injected zebrafish. (<bold>G</bold>) WISH for <italic>trpm7</italic> (PST segment) in WT, WT + <italic>sim1</italic> a MO, <italic>ppargc1a<sup>sa13186-/-</sup></italic>, and <italic>ppargc1a<sup>sa13186-/-</sup></italic> + <italic>sim1a</italic> MO zebrafish. The green and red dashed lines indicate the beginning and end of WT <italic>trpm7</italic> expression domains respectively. Asterisks represent expanded expression domain. Scale bars = 100 μm. (<bold>H</bold>) Absolute length measurements for the <italic>trpm7</italic> domain in WT, <italic>sim1a</italic> MO injected, <italic>ppargc1a<sup>sa13186-/-</sup></italic>, and <italic>ppargc1a<sup>sa13186-/-</sup> sim1a</italic> MO injected zebrafish. (<bold>I</bold>) Expression summary table depicting the segment boundaries and expression domains of <italic>ppargc1a</italic> and <italic>sim1a</italic> in WT, <italic>sim1a-</italic>deficient, <italic>ppargc1a-</italic>deficient, and double-deficient zebrafish. (<bold>J</bold>) Genetic model illustrating the relationships supported in this study that <italic>ppargc1a</italic> works upstream of <italic>tbx2b</italic> to form the DL and has a cross-repressive relationship with <italic>sim1a</italic> to properly form the segment boundary of the PST. Data are represented as ±SD, significant by t test, n.s. = not significant, *** = p &lt; 0.001.</p></caption><graphic mime-subtype="x-tiff" mimetype="image" xlink:href="elife-40266-fig5-v2"/></fig><fig id="fig5s1" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.40266.020</object-id><label>Figure 5—figure supplement 1.</label><caption><title><italic>sim1a</italic> knockdown was verified by reverse transcriptase PCR and known <italic>sim1a</italic> deficient phenotypes.</title><p>(<bold>A</bold>) WISH for previously published <italic>sim1a</italic> deficient phenotypes including the PST (top - <italic>trpm7</italic>) and CS (bottom - <italic>stc1</italic>) in WT (left) and <italic>sim1a</italic> MO injected (right) zebrafish. Scale bars = 100 μm. (<bold>B</bold>) RT-PCR showing a larger band in the <italic>sim1a</italic> MO lane of the gel and a schematic illustrating the results of sequencing the MO injected band verifying disrupted splicing of the <italic>sim1a</italic> transcripts.</p></caption><graphic mime-subtype="x-tiff" mimetype="image" xlink:href="elife-40266-fig5-figsupp1-v2"/></fig><fig id="fig5s2" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.40266.021</object-id><label>Figure 5—figure supplement 2.</label><caption><title>The CS is expanded in <italic>ppargc1a-</italic>deficient zebrafish.</title><p>(<bold>A</bold>) Double WISH for <italic>stc1</italic> (purple) and <italic>slc12a3</italic> (red) in WT and <italic>ppargc1a<sup>sa13186-/-</sup></italic>. The DL was stained as an internal control to ID mutants that were later verified either by sequencing or the restriction enzyme digest previously described. Scale bars = 100 μm (4 x image) and 50 μm (inset). (<bold>B</bold>) Graph indicating <italic>stc1</italic><sup>+</sup> cell numbers in WT compared to <italic>ppargc1a<sup>sa13186-/-</sup></italic>. (<bold>C</bold>) WISH at 28 ss for <italic>sim1a</italic> (purple) in WT (top) and <italic>ppargc1a</italic> cRNA injected (middle) and double WISH for <italic>sim1a</italic> (purple) and <italic>slc12a3</italic> (red) in <italic>ppargc1a<sup>sa13186-/-</sup></italic>. Scale bars = 100 μm (4 x image) and 50 μm (inset). (<bold>D</bold>) Graph indicating the number of <italic>sim1a</italic><sup>+</sup> cells in the WT CS compared to <italic>ppargc1a<sup>sa13186-/-</sup></italic> and <italic>ppargc1a</italic> cRNA injected zebrafish. Data are represented as ±SD, significant by t test, *** = p &lt; 0.001. (<bold>E</bold>) Genetic model depicting the cross-repressive interactions between <italic>ppargc1a</italic> and <italic>sim1a</italic> that result in the CS.</p></caption><graphic mime-subtype="x-tiff" mimetype="image" xlink:href="elife-40266-fig5-figsupp2-v2"/></fig><fig id="fig5s3" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.40266.022</object-id><label>Figure 5—figure supplement 3.</label><caption><title><italic>sim1a</italic> overexpression does not affect DL segment development.</title><p>(<bold>A</bold>) WISH for <italic>slc12a3</italic> (DL) in WT (top) and <italic>sim1a</italic> cRNA injected 28 ss zebrafish embryos. Scale bar = 100 μm. (<bold>B</bold>) Graph indicating the <italic>slc12a3</italic> domain length in WT compared to <italic>sim1a</italic> cRNA overexpression. Data are represented as ±SD, and were not significant by t test, n.s. = not significant.</p></caption><graphic mime-subtype="x-tiff" mimetype="image" xlink:href="elife-40266-fig5-figsupp3-v2"/></fig></fig-group><p>Since <italic>ppargc1a<sup>sa13186-/-</sup></italic> mutants evince an increased PST segment (<xref ref-type="fig" rid="fig2">Figure 2B,C</xref>) in addition to an increased CS size (<xref ref-type="fig" rid="fig5s2">Figure 5—figure supplement 2A,B</xref>), we next examined whether Ppargc1a deficiency was associated with changes in <italic>sim1a</italic> expression in renal precursors. WISH was performed to investigate the pattern of <italic>sim1a</italic> expression in <italic>ppargc1a<sup>sa13186-/-</sup></italic> mutant embryos. This analysis revealed that <italic>ppargc1a<sup>sa13186-/-</sup></italic> mutant embryos had an increased <italic>sim1a</italic> domain at the 20 ss, a time point that coincides with <italic>sim1a</italic> expression in the PCT and PST segments, as well as at the 28 ss, which coincides with expression of <italic>sim1a</italic> in the CS anlage (<xref ref-type="fig" rid="fig5">Figure 5B,E</xref>, <xref ref-type="fig" rid="fig5s2">Figure 5—figure supplement 2C,D</xref>). Taken together, these results suggested that there were reciprocal antagonistic interactions between these two factors, which act to delineate segmental domains.</p><p>To further explore cross-repressive interactions, we next performed RNA overexpression studies with <italic>sim1a</italic> and <italic>ppargc1a</italic> in WT embryos. Interestingly, overexpression of <italic>sim1a</italic> cRNA led to a statistically significant decrease in the domain of <italic>ppargc1a</italic> transcript expression within the pronephros at the 28 ss (<xref ref-type="fig" rid="fig5">Figure 5A,D</xref>), as well as an increase in PST segment length (<xref ref-type="fig" rid="fig5">Figure 5C,F</xref>), the latter as previously reported (<xref ref-type="bibr" rid="bib11">Cheng and Wingert, 2015</xref>). <italic>sim1a</italic> cRNA overexpression also had no effect on DL segment development (<xref ref-type="fig" rid="fig5s3">Figure 5—figure supplement 3</xref>), consistent with intact <italic>ppargc1a</italic> expression in the distal pronephros region (<xref ref-type="fig" rid="fig5">Figure 5A</xref>). Overexpression of <italic>ppargc1a</italic> cRNA caused a statistically significant decrease in the domain of <italic>sim1a</italic> transcript expression within the pronephros at the 20 ss (<xref ref-type="fig" rid="fig5">Figure 5B,E</xref>) as well as the CS anlage at the 28 ss (<xref ref-type="fig" rid="fig5s2">Figure 5—figure supplement 2C,D</xref>). <italic>ppargc1a</italic> cRNA overexpression also reduced the PST segment length at the 28 ss (<xref ref-type="fig" rid="fig5">Figure 5C,F</xref>). These results support the conclusion that <italic>sim1a</italic> and <italic>ppargc1a</italic> have repressive effects on each other in the context of renal progenitor development in the zebrafish.</p><p>In light of the observation that <italic>sim1a</italic> cRNA overexpression is sufficient to expand the PST segment (<xref ref-type="fig" rid="fig5">Figure 5C,E</xref>) (<xref ref-type="bibr" rid="bib11">Cheng and Wingert, 2015</xref>), we hypothesized that the expansion of the <italic>sim1a</italic> expression in <italic>ppargc1a</italic> mutants was responsible for the enlarged PST phenotype. To interrogate this and gain further insight about the relationship between <italic>ppargc1a</italic> and <italic>sim1a</italic>, we tested the outcome of <italic>sim1a</italic> knockdown in <italic>ppargc1a</italic> mutants compared to WT embryos. <italic>sim1a</italic> MO was injected at the one-cell stage into <italic>ppargc1a<sup>sa13186</sup></italic> heterozygous in-crosses, and nephron segmentation was assessed in these and uninjected controls by WISH at the 28 ss to study PST development. Consistent with our previous results, <italic>sim1a</italic> deficiency abrogated the PST in WT embryos, and there was a larger PST in the <italic>ppargc1a<sup>sa13186-/-</sup></italic> mutants (<xref ref-type="fig" rid="fig5">Figure 5G,H</xref>). By comparison, <italic>ppargc1a/sim1a</italic> doubly deficient embryos formed a PST segment of normal length (<xref ref-type="fig" rid="fig5">Figure 5G,H</xref>). Taken together, these results suggest that <italic>sim1a</italic> promotes PST fate by acting to control the expression domain of <italic>ppargc1a</italic> in proximal renal progenitors, which establishes the proper boundary of the PST segments (<xref ref-type="fig" rid="fig5">Figure 5I</xref>). Additionally, these results show that <italic>ppargc1a</italic> serves an antagonistic role to <italic>sim1a</italic>, restricting the spatial domain of <italic>sim1a</italic> expression from distal renal progenitors to define the PST segment boundary (<xref ref-type="fig" rid="fig5">Figure 5I</xref>).</p></sec></sec><sec id="s3" sec-type="discussion"><title>Discussion</title><p>Elucidating the genetic regulators that direct cell fate decisions during nephron ontogeny is paramount to understanding how molecular changes cause renal organogenesis defects, and can be applied to advance regenerative medicine approaches for the treatment of kidney disease. Evidence from our chemical genetic screen led us to identify that PPAR signaling was a possible candidate for regulating the nephron segment lineages during embryogenesis. Here, we determined that <italic>ppargc1a</italic> expression in renal progenitors is essential to mitigate segment fate choices that establish segment identities in the pronephros.</p><p>Specifically, we discovered that <italic>ppargc1a</italic> is necessary for proper formation of the PST and DL segment boundaries. We also identified the timing associated with these segmentation changes and observed cellular turnover analogous to WT embryos, suggesting that segment phenotypes in <italic>ppargc1a</italic> mutants are not related to alterations in cell proliferation or cell death. We ascertained that there are two critical genetic pathways that <italic>ppargc1a</italic> regulates to control PST and DL segment size. Through a series of genetic studies, we determined that <italic>ppargc1a</italic> acts upstream of <italic>tbx2b</italic> to promote DL formation and we uncovered an intriguing, reciprocally antagonistic relationship between <italic>sim1a</italic> and <italic>ppargc1a</italic> that operates to properly form the PST segment (<xref ref-type="fig" rid="fig5">Figure 5J</xref>), as well as the CS anlage (<xref ref-type="fig" rid="fig5s2">Figure 5—figure supplement 2</xref>). Discovery of the opposing activities of <italic>ppargc1a</italic> and <italic>sim1a</italic> in the present work highlights for the first time how the precise dimension of the PST is defined by reciprocal antagonism during segmentation of the kidney nephron unit. While this interplay is essential for segment fate choice, a fascinating aspect revealed by our studies is that there is an underlying genetic network that enables PST segment development to transpire normally in the absence of both of these powerful opposing transcription factors. Future efforts to identify these other genetic components are needed to decipher the mechanisms of PST formation, where there have been few advances in understanding the patterning of this segment despite progress in understanding ciliated cell fate choice in this pronephros region (<xref ref-type="bibr" rid="bib45">Marra et al., 2016</xref>). With respect to DL segment ontogeny, additional work is also needed to ascertain how <italic>ppargc1a</italic> relates to known DL regulators such as the transcription factors <italic>mecom</italic>, <italic>tbx2a</italic>, and <italic>emx1</italic> along with prostaglandin signaling (<xref ref-type="bibr" rid="bib37">Li et al., 2014</xref>; <xref ref-type="bibr" rid="bib17">Drummond et al., 2017</xref>; <xref ref-type="bibr" rid="bib61">Poureetezadi et al., 2016</xref>; <xref ref-type="bibr" rid="bib52">Morales et al., 2018</xref>).</p><p>Previous studies have established that PGC-1α can exert its regulatory effects on the transcription of target genes in cell-specific contexts through its interactions with a variety of nuclear receptors. Transcriptional regulation by PGC-1α is known to play key roles in diverse biological processes, from mitochondrial biogenesis to metabolic activities, in which PGC-1α coordinates dynamic responses to physiological demands (<xref ref-type="bibr" rid="bib40">Lin et al., 2005</xref>). Additionally, PGC-1α coordinates transcriptional activities during cell differentiation, such as in erythrocyte maturation, where it has unique and shared nuclear targets with its family member PGC-1α that impact globin gene regulation (<xref ref-type="bibr" rid="bib12">Cui et al., 2014</xref>). Transcriptional profiling of renal progenitors in <italic>ppargc1a</italic> mutants, assessment of chromatin state with techniques such as the assay for transposase accessible chromatin using sequencing (ATAC-seq) and chromatin immunoprecipitation with sequencing (ChIP-Seq), can delineate the possible direct and indirect targets of Ppargc1a. As coactivators typically function in multiprotein complexes, identification of both the relevant nuclear receptor targets and other binding partners of Ppargc1a in renal progenitors will be crucial to gaining additional insight on the emergence of nephron segment populations and the establishment of boundaries between adjacent segments. The precedence that members of the PGC-1 family can have redundant activities suggests that future investigations should also explore this possibility for Ppargc1a during nephron segmentation (<xref ref-type="bibr" rid="bib12">Cui et al., 2014</xref>). Such redundancy might explain the absence of congenital kidney defects in the PGC-1α murine knockout, and may necessitate combined deficiency studies to delineate the roles of PGC-1 members in mammalian renal development.</p><p>Further explorations of the mechanisms by which Ppargc1a regulates renal progenitors should also consider possibilities in addition to transcriptional control because of the precedence that PGC-1α possesses a number of molecular activities depending on the context. PGC-1α is highly versatile, whereby it can interact with a range of molecules other than transcription factors. PGC-1α can recruit histone acetyl transferase containing coactivator proteins and can also interact with RNA processing complexes (<xref ref-type="bibr" rid="bib32">Knutti and Kralli, 2001</xref>; <xref ref-type="bibr" rid="bib65">Puigserver and Spiegelman, 2003</xref>). Proteomics approaches in renal progenitors may thus identify Ppargc1a binding partners with such activities and if so, will highlight other directions by which to elucidate the roles of Ppargc1a during nephron segmentation.</p><p>While functions for Ppargc1a in vertebrate renal development have not been reported until the present study, interesting roles of PGC-1α have been identified during the response to kidney damage in mammals. PGC-1α serves a renoprotective function in the murine kidney. PGC-1α is downregulated after ischemic and sepsis induced acute kidney injury, and normal renal function is restored with overexpression of PGC-1α (<xref ref-type="bibr" rid="bib73">Tran et al., 2011</xref>; <xref ref-type="bibr" rid="bib74">Tran et al., 2016</xref>). PGC-1α is also reduced in three different modes of chronic kidney disease: toxic, obstructive, and genetic (<xref ref-type="bibr" rid="bib27">Han et al., 2017</xref>). <italic>Hes1</italic> represses <italic>ppargc1a</italic> during Notch-induced renal fibrosis; however, induced overexpression of <italic>ppargc1a</italic> can ameliorate this process (<xref ref-type="bibr" rid="bib27">Han et al., 2017</xref>). In light of the potent influence that Ppargc1a exacts on renal progenitors during embryonic kidney development, it is intriguing to speculate whether modulation of Ppargc1a could be utilized further to stimulate regenerative therapies. In addition, Ppargc1a is a prime candidate for being involved in the capacity of the zebrafish adult to regenerate nephrons and undergo neonephrogenesis, where the prediction would be that Ppargc1a is similarly essential in nephron precursors to mitigate emergence of the PST and DL segment fates (<xref ref-type="bibr" rid="bib15">Diep et al., 2011</xref>; <xref ref-type="bibr" rid="bib50">McCampbell and Wingert, 2014</xref>; <xref ref-type="bibr" rid="bib48">McCampbell et al., 2014</xref>; <xref ref-type="bibr" rid="bib49">McCampbell et al., 2015</xref>; <xref ref-type="bibr" rid="bib18">Drummond and Wingert, 2016</xref>).</p><p>While there have been ongoing advancements in our understanding of nephron patterning during development and the pathways that facilitate nephron epithelial regeneration following damage, many gaps in knowledge still remain. The continued identification of the genetic networks that regulate renal progenitors in these contexts has far-reaching implications (<xref ref-type="bibr" rid="bib7">Chambers and Wingert, 2016</xref>). Our new insights into nephron segmentation have divulged novel mechanisms that define nephron segment boundaries in the embryonic renal mesoderm. Taken together, our data show for the first time that <italic>ppargc1a</italic> is required for pivotal renal progenitor fate decisions that establish nephron segment pattern during kidney development. Given the fundamental conservation of segment pattern across vertebrate nephrons, we speculate that these newly discovered roles of Ppargc1a will provide useful clues about PGC-1α functions in mammalian kidney development. As alterations in Ppargc1a activity have potent effects on nephron segment fate, our results suggest that Ppargc1a/PGC-1α may be an important molecular target for medical applications or engineering approaches involving the directed differentiation of pluripotent stem cells to fashion kidney organoids (<xref ref-type="bibr" rid="bib8">Chambers et al., 2016</xref>). Here, we have only begun to appreciate the importance of <italic>ppargc1a</italic> in kidney development, focusing on the role it plays in segment boundary formation.</p></sec><sec id="s4" sec-type="materials|methods"><title>Materials and methods</title><table-wrap id="keyresource" position="anchor"><label>Key resources table</label><table frame="hsides" rules="groups"><thead><tr><th valign="top">Reagent type <break/>(species) or resource</th><th valign="top">Designation</th><th valign="top">Source or reference</th><th valign="top">Identifiers</th><th valign="top">Additional <break/>information</th></tr></thead><tbody><tr><td valign="top">Antibody</td><td valign="top">anti-Caspase-3 (rabbit)</td><td valign="top">BD Biosciences</td><td valign="top">559565</td><td valign="top">dilution 1:100</td></tr><tr><td valign="top">Antibody</td><td valign="top">phospho-Histone H3 (Ser10) (rabbit)</td><td valign="top">Millipore</td><td valign="top">06–570</td><td valign="top">dilution 1:200</td></tr><tr><td valign="top">Antibody</td><td valign="top">Alexa Fluor anti-rabbit secondary (goat)</td><td valign="top">Invitrogen</td><td valign="top">A11037</td><td valign="top">dilution 1:500</td></tr><tr><td valign="top">Chemical compound, drug</td><td valign="top">dimethyl sulfoxide (DMSO)</td><td valign="top">American Bioanalytical</td><td valign="top">AB03091-00100</td><td valign="top"/></tr><tr><td valign="top">Chemical compound, drug</td><td valign="top">bezafibrate</td><td valign="top">Enzo Life Sciences</td><td valign="top">BML-GR211-0001</td><td valign="top"/></tr><tr><td valign="top">Genetic reagent (<italic>Danio rerio</italic>)</td><td valign="top"><italic>ppargc1a<sup>sa13186</sup></italic> zebrafish line</td><td valign="top">Zebrafish International Resource Center <break/>(ZIRC)</td><td valign="top">ZMP:sa13186</td><td valign="top">Zebrafish Mutation Project allele sa13186</td></tr><tr><td valign="top">Commercial <break/>assay or kit</td><td valign="top">PCR purification kit</td><td valign="top">Qiagen</td><td valign="top">28106</td><td valign="top"/></tr><tr><td valign="top">Commercial <break/>assay or kit</td><td valign="top">NdeI restriction endonuclease enzyme</td><td valign="top">New England BioLabs</td><td valign="top">R0111S</td><td valign="top"/></tr><tr><td valign="top">Commercial <break/>assay or kit</td><td valign="top">TRIzol Reagent</td><td valign="top">Invitrogen</td><td valign="top">15596018</td><td valign="top"/></tr><tr><td valign="top">Commercial <break/>assay or kit</td><td valign="top">qScript cDNA SuperMix</td><td valign="top">QuantaBio</td><td valign="top">VWR 101414–106</td><td valign="top"/></tr><tr><td valign="top">Commercial <break/>assay or kit</td><td valign="top">PerfeCTa SYBR Green <break/>SuperMix with ROX</td><td valign="top">QuantaBio</td><td valign="top">VWR 101414–160</td><td valign="top"/></tr><tr><td valign="top">Chemical compound, drug</td><td valign="top">mMESSAGE mMACHINE <break/>SP6 Transcription kit</td><td valign="top">Ambion</td><td valign="top">AM1340</td><td valign="top"/></tr><tr><td valign="top">Other</td><td valign="top">custom antisense <break/>morpholino oligonucleotide</td><td valign="top">Gene Tools, LLC</td><td valign="top"><italic>ppargc1a</italic> ATG MO1 (ZFIN: MO1-ppargc1a)</td><td valign="top">5’–CCTGATTACACCTGTCCCACGCCAT–3’</td></tr><tr><td valign="top">Other</td><td valign="top">custom antisense <break/>morpholino oligonucleotide</td><td valign="top">Gene Tools, LLC</td><td valign="top"><italic>ppargc1a</italic> SB MO1</td><td valign="top">5’–GGAGCTTCTTCAGCTACAAACAGAG–3’</td></tr><tr><td valign="top">Other</td><td valign="top">custom antisense <break/>morpholino oligonucleotide</td><td valign="top">Gene Tools, LLC</td><td valign="top"><italic>ppargc1a</italic> SB MO2</td><td valign="top">5’–GGTGAGCAGCTACCTTGGCAACAGC–3’</td></tr><tr><td valign="top">Other</td><td valign="top">custom antisense <break/>morpholino oligonucleotide</td><td valign="top">Gene Tools, LLC</td><td valign="top"><italic>tbx2b</italic> MO</td><td valign="top">5’–CCTGTAAAAACTGGATCTCTCATCGG–3’</td></tr><tr><td valign="top">Other <break/></td><td valign="top">custom antisense <break/>morpholino <break/>oligonucleotide</td><td valign="top">Gene Tools, LLC</td><td valign="top"><italic>sim1a MO</italic></td><td valign="top">5’–TGTGATTGTGTACCTGAAGCAGATG–3’</td></tr><tr><td valign="top">Software, algorithm</td><td valign="top">Nikon Elements imaging <break/>software</td><td valign="top">Nikon</td><td valign="top"/><td valign="top"/></tr><tr><td valign="top">Software, algorithm</td><td valign="top">Graphpad Prism 8</td><td valign="top">GraphPad Prism <break/>(<ext-link ext-link-type="uri" xlink:href="https://www.graphpad.com/scientific-software/prism/">https://www.graphpad.com/scientific-software/prism/</ext-link>)</td><td valign="top"/><td valign="top"/></tr><tr><td valign="top">Software, algorithm</td><td valign="top">ImageJ</td><td valign="top">ImageJ (<ext-link ext-link-type="uri" xlink:href="https://imagej.nih.gov/ij/">https://imagej.nih.gov/ij/</ext-link>)</td><td valign="top"/><td valign="top"/></tr></tbody></table></table-wrap><sec id="s4-1"><title>Zebrafish husbandry and ethics statement</title><p>Zebrafish were maintained in the Center for Zebrafish Research at the University of Notre Dame. All studies were performed with approval of the University of Notre Dame Institutional Animal Care and Use Committee (IACUC), under protocol numbers 13–021 and 16–025. For experiments with WT zebrafish, we utilized the Tübingen strain. Embryos were raised and staged as described (<xref ref-type="bibr" rid="bib31">Kimmel et al., 1995</xref>). For all molecular studies, embryos were incubated in E3 medium from fertilization through the desired developmental stage at 28°C, anesthetized with 0.02% tricaine, and then fixed for analysis using 4% paraformaldehyde/1 x phosphate buffered saline (<xref ref-type="bibr" rid="bib76">Westerfield, 1993</xref>).</p></sec><sec id="s4-2"><title>Whole mount and fluorescent whole mount <italic>in situ</italic> hybridization (WISH, FISH)</title><p>WISH was performed as previously described (<xref ref-type="bibr" rid="bib9">Cheng et al., 2014</xref>; <xref ref-type="bibr" rid="bib21">Galloway et al., 2008</xref>; <xref ref-type="bibr" rid="bib36">Lengerke et al., 2011</xref>) with antisense RNA probes either digoxigenin-labeled (<italic>ppargc1a, slc20a1a, trpm7, slc12a1, slc12a3, sim1a, tbx2b, stc1, cdh17</italic>) or fluorescein-labeled (<italic>smyhc, slc12a3, -slc12a1, pax2a</italic>) by <italic>in vitro</italic> transcription using IMAGE clone templates as previously described (<xref ref-type="bibr" rid="bib77">Wingert et al., 2007</xref>; <xref ref-type="bibr" rid="bib56">O'Brien et al., 2011</xref>; <xref ref-type="bibr" rid="bib24">Gerlach and Wingert, 2014</xref>; <xref ref-type="bibr" rid="bib51">McKee et al., 2014</xref>). FISH was performed as previously described (<xref ref-type="bibr" rid="bib4">Brend and Holley, 2009</xref>; <xref ref-type="bibr" rid="bib46">Marra et al., 2017</xref>). For all gene expression studies, every analysis was done in triplicate for each genetic model, in a blinded fashion, with sample sizes of at least n = 20 for each replicate. A minimum of 5 representative individuals from each replicate were imaged and quantified, then subjected to statistical analysis.</p></sec><sec id="s4-3"><title>Immunofluorescence (IF)</title><p>Whole mount IF experiments were completed as previously described (<xref ref-type="bibr" rid="bib34">Kroeger et al., 2017</xref>; <xref ref-type="bibr" rid="bib46">Marra et al., 2017</xref>). For cell death and proliferation assays, rabbit anti-Caspase-3 diluted 1:100 (BD Biosciences 559565) and rabbit phospho-Histone H3 (Ser10) antibody diluted 1:200 (Millipore 06–570) were used, respectively. Anti-rabbit secondary antibody (Alexa Fluor, Invitrogen) was diluted 1:500.</p></sec><sec id="s4-4"><title>Chemical treatments</title><p>Chemical treatments were completed as previously described (<xref ref-type="bibr" rid="bib60">Poureetezadi et al., 2014</xref>; <xref ref-type="bibr" rid="bib61">Poureetezadi et al., 2016</xref>). Bezafibrate (Enzo Life Sciences, BML-GR211-0001) was dissolved in 100% DMSO to make 1 M stocks and diluted to the working dosage. For segment analysis, treatments were completed in triplicate with sample sizes of at least 20 embryos per replicate.</p></sec><sec id="s4-5"><title>Genetic models</title><p>The <italic>ppargc1a<sup>sa13186</sup></italic> line was obtained from ZIRC (Eugene, OR) (<xref ref-type="bibr" rid="bib5">Busch-Nentwich et al., 2013</xref>). Mutant embryos and heterozygous adults were identified by performing PCR with the following primers flanking the mutation site: forward <named-content content-type="sequence">5’–</named-content><named-content content-type="sequence">GGGCCGGCATGTGGAATGTAAAGACTTAAACATGCCAACCTCCACTACTACGACATCATCGTTGTCTTCCACCCCCCCTTCGTCTTCCTCACTGGCCA</named-content> <named-content content-type="sequence">GG–3</named-content>’ and reverse <named-content content-type="sequence">5’–</named-content><named-content content-type="sequence">TCCCACTACCCCGCTATAGAAGGCTTGCTGAGGCTTTCCAAAGTGCTTGTTGAGCTCGTCCCGGATCTCCTGGTCCCTAAGAAGTTTCCTGCCACCAGAA</named-content><named-content content-type="sequence">–3’</named-content>. PCR products were purified (Qiagen) and sent to the Notre Dame Genomics Core for sequencing analysis or subjected to restriction enzyme digest with NdeI (New England BioLabs) and separation on a 2% agarose gel to identify WT, heterozygous, or mutant samples. Antisense morpholino oligonucleotides (MOs) were obtained from Gene Tools, LLC (Philomath, OR) and solubilized in DNase/RNase-free water to create 4 mM stock solutions which were then stored at −20°C. Zebrafish embryos were injected at the 1 cell stage with 1–2 nL of diluted MO. <italic>ppargc1a</italic> was targeted with the following: ATG MO1 ‘MO1’ 5’–<named-content content-type="sequence">CCTGATTACACCTGTCCCACGCCAT</named-content>–3’ (400 µM) (<xref ref-type="bibr" rid="bib28">Hanai et al., 2007</xref>; <xref ref-type="bibr" rid="bib3">Bertrand et al., 2007</xref>), Splice MO1 ‘SB MO1’ 5’–<named-content content-type="sequence">GGAGCTTCTTCAGCTACAAACAGAG</named-content>–3’ (400 µM), and Splice MO2 ‘SB MO2’ 5’–<named-content content-type="sequence">GGTGAGCAGCTACCTTGGCAACAGC</named-content>–3’ (400 µM). <italic>tbx2b</italic> knockdowns were performed with an ATG MO 5’–<named-content content-type="sequence">CCTGTAAAAACTGGATCTCTCATCGG</named-content>–3’ (400 µM) (<xref ref-type="bibr" rid="bib26">Gross and Dowling, 2005</xref>; <xref ref-type="bibr" rid="bib17">Drummond et al., 2017</xref>). To target <italic>sim1a,</italic> a splice blocking MO 5’–TGTGATTGTGTACCTGAAGCAGATG–3’ (400 µM) was used (<xref ref-type="bibr" rid="bib43">Löhr et al., 2009</xref>; <xref ref-type="bibr" rid="bib11">Cheng and Wingert, 2015</xref>). RT-PCR was completed to determine efficacy of the <italic>sim1a</italic> splice MO knockdown as previously described (<xref ref-type="bibr" rid="bib47">Marra and Wingert, 2016</xref>). To complete RT-PCR the following primers were used: <italic>ppargc1a</italic>-FWD <named-content content-type="sequence">5’–AATGCCAGTGATCAGAGCTGTCCTT–3’</named-content>, <named-content content-type="sequence">ppargc1a-RVS 5’–CAGCTCAGTGCAGGGACGTCTCATG–3’</named-content>, <italic>sim1a</italic>-FWD 5’<named-content content-type="sequence">–GAATCTTGGGGCCATGTGAGTCGAACGACTTCACTGG–3’</named-content>, <italic>sim1a</italic>-RVS <named-content content-type="sequence">5’–GTACAGGATTTTCCCATCAGGAGCCACCACAAAGATG–3</named-content>’.</p></sec><sec id="s4-6"><title>Quantitative real-time PCR</title><p>Groups of 25–30 bezafibrate treated and vehicle control zebrafish were pooled with their respective group at the 28 ss. RNA was extracted using TRIZOL (Ambion) following the manufacturer instructions. cDNA was generated by qScript cDNA SuperMix (QuantaBio). qRT-PCR reactions were completed using PerfeCTa SYBR Green SuperMix with ROX (QuantaBio). To target <italic>ppargc1a</italic>, 100 ng of cDNA was optimal. For 18S control 1 ng was optimal. Primers used to amplify <italic>ppargc1a</italic> were forward <named-content content-type="sequence">5’–AATGCCAGTGATCAGAGCTGTCCTT–3’</named-content> and reverse <named-content content-type="sequence">5’–GTTCTGTGCCTTGCCACCTGGGTAT–3’</named-content>. To target 18S the primers were as follows: forward <named-content content-type="sequence">5’–TCGGCTACCACATCCAAGGAAGGCAGC–3’</named-content> and reverse <named-content content-type="sequence">5’–TTGCTGGAATTACCGCGGCTGCTGGCA–3</named-content>’. The AB StepOnePlus quantitative real time PCR machine program was: holding stage 2 min at 50°C, holding stage for 10 min at 95°C, then cDNA was amplified during 40 cycles, alternating between 15 s at 95°C to denature the cDNA and 1 min at 62°C for primer annealing and product extension. Data were recorded after each cycle to obtain the Ct values. Three technical replicates were completed for each of the three biological replicates for both treatments with the median Ct value normalized to control. Delta delta Ct was used for data analysis with 18S as a reference gene and the results calculated as relative expression change relative to DMSO control. For statistical analysis a Student’s t test was performed using the delta Ct values obtained after normalization to the 18S reference gene.</p></sec><sec id="s4-7"><title>cRNA synthesis, and microinjections, rescue studies</title><p>The zebrafish <italic>ppargc1a</italic> ORF was cloned in to a pUC57 vector flanked by a 5’ KOZAK sequence, a Cla1 restriction enzyme site, and a SP6 promoter region, and on the 3’ by a series of STOP codons, a SV40 poly A tail, a Not1 restriction enzyme site, and a t7 promoter region. <italic>ppargc1a</italic> cRNA was generated by linearizing with Not1 and sp6 run off with the mMESSAGE mMACHINE SP6 Transcription kit (Ambion). cRNA was injected into WT and <italic>ppargc1a<sup>sa13186</sup></italic> mutants at the one-cell stage at a concentration of 900 pg. Rescue studies were completed by performing WISH on injected <italic>ppargc1a<sup>sa13186</sup></italic> mutants, then samples were imaged and genotyped. A minimum of three samples for each genotype was used to calculate segment phenotypes.</p></sec><sec id="s4-8"><title>Image acquisition and quantification of phenotypes</title><p>WISH images were acquired using a Nikon Eclipse Ni with a DS-Fi2 camera. FISH and immunofluorescence images were acquired using a Nikon C2 confocal microscope. Segment phenotypes were quantified using the Nikon Elements imaging software polyline tool. Unless otherwise stated, a minimum of three representative samples from each biological replicate were imaged and measured. Experiments were completed in triplicate. From these measurements, an average and standard deviation (SD) were calculated, and unpaired t-tests or one-way ANOVA tests were completed to compare control and experimental measurements.</p></sec></sec></body><back><ack id="ack"><title>Acknowledgements</title><p>NIH Grant R01DK100237 to RAW supported this work. We are grateful to Elizabeth and Michael Gallagher for a generous gift to the University of Notre Dame on behalf of their family for the support of stem cell research. The funders had no role in the study design, data collection and analysis, decision to publish, or manuscript preparation. We thank the staffs of the Department of Biological Sciences and the Center for Zebrafish Research at the University of Notre Dame for their dedication and care of our zebrafish aquarium. We thank ED for contributions to preliminary investigations on the effects of bezafibrate on zebrafish nephron development. We also extend special thanks to LG for assistance with analytical tools. Finally, we thank all the current and previous members of our lab for their support, discussions, and insights about this work.</p></ack><sec id="s5" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="COI-statement" id="conf1"><p>No competing interests declared</p></fn></fn-group><fn-group content-type="author-contribution"><title>Author contributions</title><fn fn-type="con" id="con1"><p>Conceptualization, Data curation, Formal analysis, Validation, Investigation, Visualization, Methodology, Writing—original draft, Project administration, Writing—review and editing</p></fn><fn fn-type="con" id="con2"><p>Conceptualization, Data curation, Formal analysis, Investigation, Methodology</p></fn><fn fn-type="con" id="con3"><p>Data curation, Formal analysis, Validation, Investigation, Visualization</p></fn><fn fn-type="con" id="con4"><p>Data curation, Formal analysis, Investigation, Methodology, Writing—review and editing</p></fn><fn fn-type="con" id="con5"><p>Conceptualization, Data curation, Formal analysis, Supervision, Funding acquisition, Validation, Investigation, Visualization, Methodology, Writing—original draft, Project administration, Writing—review and editing</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>Animal experimentation: Zebrafish were maintained in the Center for Zebrafish Research at the University of Notre Dame. All studies were performed with approval of the University of Notre Dame Institutional Animal Care and Use Committee (IACUC), under protocol numbers 13-021 and 16-025.</p></fn></fn-group></sec><sec id="s6" sec-type="supplementary-material"><title>Additional files</title><supplementary-material id="transrepform"><object-id pub-id-type="doi">10.7554/eLife.40266.023</object-id><label>Transparent reporting form</label><media mime-subtype="docx" mimetype="application" xlink:href="elife-40266-transrepform-v2.docx"/></supplementary-material><sec id="s7" sec-type="data-availability"><title>Data availability</title><p>All data generated or analysed during this study are included in the manuscript and supporting files.</p></sec></sec><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ai</surname> <given-names>K</given-names></name><name><surname>Luo</surname> <given-names>K</given-names></name><name><surname>Li</surname> <given-names>Y</given-names></name><name><surname>Hu</surname> <given-names>W</given-names></name><name><surname>Gao</surname> <given-names>W</given-names></name><name><surname>Fang</surname> <given-names>L</given-names></name><name><surname>Tian</surname> <given-names>G</given-names></name><name><surname>Ruan</surname> <given-names>G</given-names></name><name><surname>Xu</surname> <given-names>Q</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Expression pattern analysis of IRF4 and its related genes revealed the functional differentiation of IRF4 paralogues in teleost</article-title><source>Fish &amp; Shellfish Immunology</source><volume>60</volume><fpage>59</fpage><lpage>64</lpage><pub-id pub-id-type="doi">10.1016/j.fsi.2016.11.038</pub-id><pub-id pub-id-type="pmid">27856326</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arany</surname> <given-names>Z</given-names></name><name><surname>Foo</surname> <given-names>SY</given-names></name><name><surname>Ma</surname> <given-names>Y</given-names></name><name><surname>Ruas</surname> <given-names>JL</given-names></name><name><surname>Bommi-Reddy</surname> <given-names>A</given-names></name><name><surname>Girnun</surname> <given-names>G</given-names></name><name><surname>Cooper</surname> <given-names>M</given-names></name><name><surname>Laznik</surname> <given-names>D</given-names></name><name><surname>Chinsomboon</surname> <given-names>J</given-names></name><name><surname>Rangwala</surname> <given-names>SM</given-names></name><name><surname>Baek</surname> <given-names>KH</given-names></name><name><surname>Rosenzweig</surname> <given-names>A</given-names></name><name><surname>Spiegelman</surname> <given-names>BM</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>HIF-independent regulation of VEGF and angiogenesis by the transcriptional coactivator PGC-1alpha</article-title><source>Nature</source><volume>451</volume><fpage>1008</fpage><lpage>1012</lpage><pub-id pub-id-type="doi">10.1038/nature06613</pub-id><pub-id pub-id-type="pmid">18288196</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bertrand</surname> <given-names>S</given-names></name><name><surname>Thisse</surname> <given-names>B</given-names></name><name><surname>Tavares</surname> <given-names>R</given-names></name><name><surname>Sachs</surname> <given-names>L</given-names></name><name><surname>Chaumot</surname> <given-names>A</given-names></name><name><surname>Bardet</surname> <given-names>PL</given-names></name><name><surname>Escrivà</surname> <given-names>H</given-names></name><name><surname>Duffraisse</surname> <given-names>M</given-names></name><name><surname>Marchand</surname> <given-names>O</given-names></name><name><surname>Safi</surname> <given-names>R</given-names></name><name><surname>Thisse</surname> <given-names>C</given-names></name><name><surname>Laudet</surname> <given-names>V</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Unexpected novel relational links uncovered by extensive developmental profiling of nuclear receptor expression</article-title><source>PLoS Genetics</source><volume>3</volume><elocation-id>e188</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pgen.0030188</pub-id><pub-id pub-id-type="pmid">17997606</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brend</surname> <given-names>T</given-names></name><name><surname>Holley</surname> <given-names>SA</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Zebrafish Whole Mount High-Resolution Double Fluorescent In Situ Hybridization</article-title><source>Journal of Visualized Experiments</source><volume>25</volume><elocation-id>pii1229</elocation-id><pub-id pub-id-type="doi">10.3791/1229</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="data"><person-group person-group-type="author"><name><surname>Busch-Nentwich</surname> <given-names>E</given-names></name><name><surname>Kettleborough</surname> <given-names>R</given-names></name><name><surname>Dooley</surname> <given-names>CM</given-names></name><name><surname>Scahill</surname> <given-names>C</given-names></name><name><surname>Sealy</surname> <given-names>I</given-names></name><name><surname>White</surname> <given-names>R</given-names></name><name><surname>Herd</surname> <given-names>C</given-names></name><name><surname>Mehroke</surname> <given-names>S</given-names></name><name><surname>Wali</surname> <given-names>N</given-names></name><name><surname>Carruthers</surname> <given-names>S</given-names></name><name><surname>Hall</surname> <given-names>A</given-names></name><name><surname>Collins</surname> <given-names>J</given-names></name><name><surname>Gibbons</surname> <given-names>R</given-names></name><name><surname>Pusztai</surname> <given-names>Z</given-names></name><name><surname>Clark</surname> <given-names>R</given-names></name><name><surname>Stemple</surname> <given-names>DL</given-names></name></person-group><year iso-8601-date="2013">2013</year><data-title>Sanger Institute Zebrafish Mutation Project mutant data submission</data-title><source>ZFIN Direct Data Submission</source><pub-id pub-id-type="archive" xlink:href="http://zfin.org/ZDB-PUB-130425-4">ZDB-PUB-130425-4</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Casemayou</surname> <given-names>A</given-names></name><name><surname>Fournel</surname> <given-names>A</given-names></name><name><surname>Bagattin</surname> <given-names>A</given-names></name><name><surname>Schanstra</surname> <given-names>J</given-names></name><name><surname>Belliere</surname> <given-names>J</given-names></name><name><surname>Decramer</surname> <given-names>S</given-names></name><name><surname>Marsal</surname> <given-names>D</given-names></name><name><surname>Gillet</surname> <given-names>M</given-names></name><name><surname>Chassaing</surname> <given-names>N</given-names></name><name><surname>Huart</surname> <given-names>A</given-names></name><name><surname>Pontoglio</surname> <given-names>M</given-names></name><name><surname>Knauf</surname> <given-names>C</given-names></name><name><surname>Bascands</surname> <given-names>JL</given-names></name><name><surname>Chauveau</surname> <given-names>D</given-names></name><name><surname>Faguer</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Hepatocyte nuclear factor-1<italic>β</italic> controls mitochondrial respiration in renal tubular cells</article-title><source>Journal of the American Society of Nephrology</source><volume>28</volume><fpage>3205</fpage><lpage>3217</lpage><pub-id pub-id-type="doi">10.1681/ASN.2016050508</pub-id><pub-id pub-id-type="pmid">28739648</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chambers</surname> <given-names>BE</given-names></name><name><surname>Wingert</surname> <given-names>RA</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Renal progenitors: Roles in kidney disease and regeneration</article-title><source>World Journal of Stem Cells</source><volume>8</volume><fpage>367</fpage><lpage>375</lpage><pub-id pub-id-type="doi">10.4252/wjsc.v8.i11.367</pub-id><pub-id pub-id-type="pmid">27928463</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chambers</surname> <given-names>JM</given-names></name><name><surname>McKee</surname> <given-names>RA</given-names></name><name><surname>Drummond</surname> <given-names>BE</given-names></name><name><surname>Wingert</surname> <given-names>RA</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Evolving technology: creating kidney organoids from stem cells</article-title><source>AIMS Bioengineering</source><volume>3</volume><fpage>305</fpage><lpage>318</lpage><pub-id pub-id-type="doi">10.3934/bioeng.2016.3.305</pub-id><pub-id pub-id-type="pmid">28393110</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cheng</surname> <given-names>CN</given-names></name><name><surname>Li</surname> <given-names>Y</given-names></name><name><surname>Marra</surname> <given-names>AN</given-names></name><name><surname>Verdun</surname> <given-names>V</given-names></name><name><surname>Wingert</surname> <given-names>RA</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Flat mount preparation for observation and analysis of zebrafish embryo specimens stained by whole mount in situ hybridization</article-title><source>Journal of Visualized Experiments</source><volume>89</volume><elocation-id>e51604</elocation-id><pub-id pub-id-type="doi">10.3791/51604</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cheng</surname> <given-names>CN</given-names></name><name><surname>Verdun</surname> <given-names>VA</given-names></name><name><surname>Wingert</surname> <given-names>RA</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Recent advances in elucidating the genetic mechanisms of nephrogenesis using zebrafish</article-title><source>Cells</source><volume>4</volume><fpage>218</fpage><lpage>233</lpage><pub-id pub-id-type="doi">10.3390/cells4020218</pub-id><pub-id pub-id-type="pmid">26024215</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cheng</surname> <given-names>CN</given-names></name><name><surname>Wingert</surname> <given-names>RA</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Nephron proximal tubule patterning and corpuscles of Stannius formation are regulated by the sim1a transcription factor and retinoic acid in zebrafish</article-title><source>Developmental Biology</source><volume>399</volume><fpage>100</fpage><lpage>116</lpage><pub-id pub-id-type="doi">10.1016/j.ydbio.2014.12.020</pub-id><pub-id pub-id-type="pmid">25542995</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cui</surname> <given-names>S</given-names></name><name><surname>Tanabe</surname> <given-names>O</given-names></name><name><surname>Lim</surname> <given-names>KC</given-names></name><name><surname>Xu</surname> <given-names>HE</given-names></name><name><surname>Zhou</surname> <given-names>XE</given-names></name><name><surname>Lin</surname> <given-names>JD</given-names></name><name><surname>Shi</surname> <given-names>L</given-names></name><name><surname>Schmidt</surname> <given-names>L</given-names></name><name><surname>Campbell</surname> <given-names>A</given-names></name><name><surname>Shimizu</surname> <given-names>R</given-names></name><name><surname>Yamamoto</surname> <given-names>M</given-names></name><name><surname>Engel</surname> <given-names>JD</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>PGC-1 coactivator activity is required for murine erythropoiesis</article-title><source>Molecular and Cellular Biology</source><volume>34</volume><fpage>1956</fpage><lpage>1965</lpage><pub-id pub-id-type="doi">10.1128/MCB.00247-14</pub-id><pub-id pub-id-type="pmid">24662048</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>D'Errico</surname> <given-names>I</given-names></name><name><surname>Salvatore</surname> <given-names>L</given-names></name><name><surname>Murzilli</surname> <given-names>S</given-names></name><name><surname>Lo Sasso</surname> <given-names>G</given-names></name><name><surname>Latorre</surname> <given-names>D</given-names></name><name><surname>Martelli</surname> <given-names>N</given-names></name><name><surname>Egorova</surname> <given-names>AV</given-names></name><name><surname>Polishuck</surname> <given-names>R</given-names></name><name><surname>Madeyski-Bengtson</surname> <given-names>K</given-names></name><name><surname>Lelliott</surname> <given-names>C</given-names></name><name><surname>Vidal-Puig</surname> <given-names>AJ</given-names></name><name><surname>Seibel</surname> <given-names>P</given-names></name><name><surname>Villani</surname> <given-names>G</given-names></name><name><surname>Moschetta</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Peroxisome proliferator-activated receptor- coactivator 1- (PGC1 ) is a metabolic regulator of intestinal epithelial cell fate</article-title><source>Proceedings of the National Academy of Sciences</source><volume>108</volume><fpage>6603</fpage><lpage>6608</lpage><pub-id pub-id-type="doi">10.1073/pnas.1016354108</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Desgrange</surname> <given-names>A</given-names></name><name><surname>Cereghini</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Nephron Patterning: Lessons from xenopus, zebrafish, and mouse studies</article-title><source>Cells</source><volume>4</volume><fpage>483</fpage><lpage>499</lpage><pub-id pub-id-type="doi">10.3390/cells4030483</pub-id><pub-id pub-id-type="pmid">26378582</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Diep</surname> <given-names>CQ</given-names></name><name><surname>Ma</surname> <given-names>D</given-names></name><name><surname>Deo</surname> <given-names>RC</given-names></name><name><surname>Holm</surname> <given-names>TM</given-names></name><name><surname>Naylor</surname> <given-names>RW</given-names></name><name><surname>Arora</surname> <given-names>N</given-names></name><name><surname>Wingert</surname> <given-names>RA</given-names></name><name><surname>Bollig</surname> <given-names>F</given-names></name><name><surname>Djordjevic</surname> <given-names>G</given-names></name><name><surname>Lichman</surname> <given-names>B</given-names></name><name><surname>Zhu</surname> <given-names>H</given-names></name><name><surname>Ikenaga</surname> <given-names>T</given-names></name><name><surname>Ono</surname> <given-names>F</given-names></name><name><surname>Englert</surname> <given-names>C</given-names></name><name><surname>Cowan</surname> <given-names>CA</given-names></name><name><surname>Hukriede</surname> <given-names>NA</given-names></name><name><surname>Handin</surname> <given-names>RI</given-names></name><name><surname>Davidson</surname> <given-names>AJ</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Identification of adult nephron progenitors capable of kidney regeneration in zebrafish</article-title><source>Nature</source><volume>470</volume><fpage>95</fpage><lpage>100</lpage><pub-id pub-id-type="doi">10.1038/nature09669</pub-id><pub-id pub-id-type="pmid">21270795</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Diez-Roux</surname> <given-names>G</given-names></name><name><surname>Banfi</surname> <given-names>S</given-names></name><name><surname>Sultan</surname> <given-names>M</given-names></name><name><surname>Geffers</surname> <given-names>L</given-names></name><name><surname>Anand</surname> <given-names>S</given-names></name><name><surname>Rozado</surname> <given-names>D</given-names></name><name><surname>Magen</surname> <given-names>A</given-names></name><name><surname>Canidio</surname> <given-names>E</given-names></name><name><surname>Pagani</surname> <given-names>M</given-names></name><name><surname>Peluso</surname> <given-names>I</given-names></name><name><surname>Lin-Marq</surname> <given-names>N</given-names></name><name><surname>Koch</surname> <given-names>M</given-names></name><name><surname>Bilio</surname> <given-names>M</given-names></name><name><surname>Cantiello</surname> <given-names>I</given-names></name><name><surname>Verde</surname> <given-names>R</given-names></name><name><surname>De Masi</surname> <given-names>C</given-names></name><name><surname>Bianchi</surname> <given-names>SA</given-names></name><name><surname>Cicchini</surname> <given-names>J</given-names></name><name><surname>Perroud</surname> <given-names>E</given-names></name><name><surname>Mehmeti</surname> <given-names>S</given-names></name><name><surname>Dagand</surname> <given-names>E</given-names></name><name><surname>Schrinner</surname> <given-names>S</given-names></name><name><surname>Nürnberger</surname> <given-names>A</given-names></name><name><surname>Schmidt</surname> <given-names>K</given-names></name><name><surname>Metz</surname> <given-names>K</given-names></name><name><surname>Zwingmann</surname> <given-names>C</given-names></name><name><surname>Brieske</surname> <given-names>N</given-names></name><name><surname>Springer</surname> <given-names>C</given-names></name><name><surname>Hernandez</surname> <given-names>AM</given-names></name><name><surname>Herzog</surname> <given-names>S</given-names></name><name><surname>Grabbe</surname> <given-names>F</given-names></name><name><surname>Sieverding</surname> <given-names>C</given-names></name><name><surname>Fischer</surname> <given-names>B</given-names></name><name><surname>Schrader</surname> <given-names>K</given-names></name><name><surname>Brockmeyer</surname> <given-names>M</given-names></name><name><surname>Dettmer</surname> <given-names>S</given-names></name><name><surname>Helbig</surname> <given-names>C</given-names></name><name><surname>Alunni</surname> <given-names>V</given-names></name><name><surname>Battaini</surname> <given-names>MA</given-names></name><name><surname>Mura</surname> <given-names>C</given-names></name><name><surname>Henrichsen</surname> <given-names>CN</given-names></name><name><surname>Garcia-Lopez</surname> <given-names>R</given-names></name><name><surname>Echevarria</surname> <given-names>D</given-names></name><name><surname>Puelles</surname> <given-names>E</given-names></name><name><surname>Garcia-Calero</surname> <given-names>E</given-names></name><name><surname>Kruse</surname> <given-names>S</given-names></name><name><surname>Uhr</surname> <given-names>M</given-names></name><name><surname>Kauck</surname> <given-names>C</given-names></name><name><surname>Feng</surname> <given-names>G</given-names></name><name><surname>Milyaev</surname> <given-names>N</given-names></name><name><surname>Ong</surname> <given-names>CK</given-names></name><name><surname>Kumar</surname> <given-names>L</given-names></name><name><surname>Lam</surname> <given-names>M</given-names></name><name><surname>Semple</surname> <given-names>CA</given-names></name><name><surname>Gyenesei</surname> <given-names>A</given-names></name><name><surname>Mundlos</surname> <given-names>S</given-names></name><name><surname>Radelof</surname> <given-names>U</given-names></name><name><surname>Lehrach</surname> <given-names>H</given-names></name><name><surname>Sarmientos</surname> <given-names>P</given-names></name><name><surname>Reymond</surname> <given-names>A</given-names></name><name><surname>Davidson</surname> <given-names>DR</given-names></name><name><surname>Dollé</surname> <given-names>P</given-names></name><name><surname>Antonarakis</surname> <given-names>SE</given-names></name><name><surname>Yaspo</surname> <given-names>ML</given-names></name><name><surname>Martinez</surname> <given-names>S</given-names></name><name><surname>Baldock</surname> <given-names>RA</given-names></name><name><surname>Eichele</surname> <given-names>G</given-names></name><name><surname>Ballabio</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>A high-resolution anatomical atlas of the transcriptome in the mouse embryo</article-title><source>PLoS Biology</source><volume>9</volume><elocation-id>e1000582</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pbio.1000582</pub-id><pub-id pub-id-type="pmid">21267068</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Drummond</surname> <given-names>BE</given-names></name><name><surname>Li</surname> <given-names>Y</given-names></name><name><surname>Marra</surname> <given-names>AN</given-names></name><name><surname>Cheng</surname> <given-names>CN</given-names></name><name><surname>Wingert</surname> <given-names>RA</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>The tbx2a/b transcription factors direct pronephros segmentation and corpuscle of Stannius formation in zebrafish</article-title><source>Developmental Biology</source><volume>421</volume><fpage>52</fpage><lpage>66</lpage><pub-id pub-id-type="doi">10.1016/j.ydbio.2016.10.019</pub-id><pub-id pub-id-type="pmid">27840199</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Drummond</surname> <given-names>BE</given-names></name><name><surname>Wingert</surname> <given-names>RA</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Insights into kidney stem cell development and regeneration using zebrafish</article-title><source>World Journal of Stem Cells</source><volume>8</volume><fpage>22</fpage><lpage>31</lpage><pub-id pub-id-type="doi">10.4252/wjsc.v8.i2.22</pub-id><pub-id pub-id-type="pmid">26981168</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fagerberg</surname> <given-names>L</given-names></name><name><surname>Hallström</surname> <given-names>BM</given-names></name><name><surname>Oksvold</surname> <given-names>P</given-names></name><name><surname>Kampf</surname> <given-names>C</given-names></name><name><surname>Djureinovic</surname> <given-names>D</given-names></name><name><surname>Odeberg</surname> <given-names>J</given-names></name><name><surname>Habuka</surname> <given-names>M</given-names></name><name><surname>Tahmasebpoor</surname> <given-names>S</given-names></name><name><surname>Danielsson</surname> <given-names>A</given-names></name><name><surname>Edlund</surname> <given-names>K</given-names></name><name><surname>Asplund</surname> <given-names>A</given-names></name><name><surname>Sjöstedt</surname> <given-names>E</given-names></name><name><surname>Lundberg</surname> <given-names>E</given-names></name><name><surname>Szigyarto</surname> <given-names>CA</given-names></name><name><surname>Skogs</surname> <given-names>M</given-names></name><name><surname>Takanen</surname> <given-names>JO</given-names></name><name><surname>Berling</surname> <given-names>H</given-names></name><name><surname>Tegel</surname> <given-names>H</given-names></name><name><surname>Mulder</surname> <given-names>J</given-names></name><name><surname>Nilsson</surname> <given-names>P</given-names></name><name><surname>Schwenk</surname> <given-names>JM</given-names></name><name><surname>Lindskog</surname> <given-names>C</given-names></name><name><surname>Danielsson</surname> <given-names>F</given-names></name><name><surname>Mardinoglu</surname> <given-names>A</given-names></name><name><surname>Sivertsson</surname> <given-names>A</given-names></name><name><surname>von Feilitzen</surname> <given-names>K</given-names></name><name><surname>Forsberg</surname> <given-names>M</given-names></name><name><surname>Zwahlen</surname> <given-names>M</given-names></name><name><surname>Olsson</surname> <given-names>I</given-names></name><name><surname>Navani</surname> <given-names>S</given-names></name><name><surname>Huss</surname> <given-names>M</given-names></name><name><surname>Nielsen</surname> <given-names>J</given-names></name><name><surname>Ponten</surname> <given-names>F</given-names></name><name><surname>Uhlén</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Analysis of the human tissue-specific expression by genome-wide integration of transcriptomics and antibody-based proteomics</article-title><source>Molecular &amp; Cellular Proteomics</source><volume>13</volume><fpage>397</fpage><lpage>406</lpage><pub-id pub-id-type="doi">10.1074/mcp.M113.035600</pub-id><pub-id pub-id-type="pmid">24309898</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Finger</surname> <given-names>JH</given-names></name><name><surname>Smith</surname> <given-names>CM</given-names></name><name><surname>Hayamizu</surname> <given-names>TF</given-names></name><name><surname>McCright</surname> <given-names>IJ</given-names></name><name><surname>Xu</surname> <given-names>J</given-names></name><name><surname>Law</surname> <given-names>M</given-names></name><name><surname>Shaw</surname> <given-names>DR</given-names></name><name><surname>Baldarelli</surname> <given-names>RM</given-names></name><name><surname>Beal</surname> <given-names>JS</given-names></name><name><surname>Blodgett</surname> <given-names>O</given-names></name><name><surname>Campbell</surname> <given-names>JW</given-names></name><name><surname>Corbani</surname> <given-names>LE</given-names></name><name><surname>Lewis</surname> <given-names>JR</given-names></name><name><surname>Forthofer</surname> <given-names>KL</given-names></name><name><surname>Frost</surname> <given-names>PJ</given-names></name><name><surname>Giannatto</surname> <given-names>SC</given-names></name><name><surname>Hutchins</surname> <given-names>LN</given-names></name><name><surname>Miers</surname> <given-names>DB</given-names></name><name><surname>Motenko</surname> <given-names>H</given-names></name><name><surname>Stone</surname> <given-names>KR</given-names></name><name><surname>Eppig</surname> <given-names>JT</given-names></name><name><surname>Kadin</surname> <given-names>JA</given-names></name><name><surname>Richardson</surname> <given-names>JE</given-names></name><name><surname>Ringwald</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>The mouse Gene Expression Database (GXD) update</article-title><source>Nucleic Acids Research</source><volume>32</volume><fpage>D730</fpage><lpage>D736</lpage><pub-id pub-id-type="doi">10.1093/nar/gkh069</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Galloway</surname> <given-names>JL</given-names></name><name><surname>Wingert</surname> <given-names>RA</given-names></name><name><surname>Thisse</surname> <given-names>C</given-names></name><name><surname>Thisse</surname> <given-names>B</given-names></name><name><surname>Zon</surname> <given-names>LI</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Combinatorial regulation of novel erythroid gene expression in zebrafish</article-title><source>Experimental Hematology</source><volume>36</volume><fpage>424</fpage><lpage>432</lpage><pub-id pub-id-type="doi">10.1016/j.exphem.2007.11.015</pub-id><pub-id pub-id-type="pmid">18243489</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Garnaas</surname> <given-names>MK</given-names></name><name><surname>Cutting</surname> <given-names>CC</given-names></name><name><surname>Meyers</surname> <given-names>A</given-names></name><name><surname>Kelsey</surname> <given-names>PB</given-names></name><name><surname>Harris</surname> <given-names>JM</given-names></name><name><surname>North</surname> <given-names>TE</given-names></name><name><surname>Goessling</surname> <given-names>W</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Rargb regulates organ laterality in a zebrafish model of right atrial isomerism</article-title><source>Developmental Biology</source><volume>372</volume><fpage>178</fpage><lpage>189</lpage><pub-id pub-id-type="doi">10.1016/j.ydbio.2012.09.001</pub-id><pub-id pub-id-type="pmid">22982668</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gerlach</surname> <given-names>GF</given-names></name><name><surname>Wingert</surname> <given-names>RA</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Kidney organogenesis in the zebrafish: insights into vertebrate nephrogenesis and regeneration</article-title><source>Wiley Interdisciplinary Reviews: Developmental Biology</source><volume>2</volume><fpage>559</fpage><lpage>585</lpage><pub-id pub-id-type="doi">10.1002/wdev.92</pub-id><pub-id pub-id-type="pmid">24014448</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gerlach</surname> <given-names>GF</given-names></name><name><surname>Wingert</surname> <given-names>RA</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Zebrafish pronephros tubulogenesis and epithelial identity maintenance are reliant on the polarity proteins Prkc iota and zeta</article-title><source>Developmental Biology</source><volume>396</volume><fpage>183</fpage><lpage>200</lpage><pub-id pub-id-type="doi">10.1016/j.ydbio.2014.08.038</pub-id><pub-id pub-id-type="pmid">25446529</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goto</surname> <given-names>T</given-names></name><name><surname>Hirata</surname> <given-names>M</given-names></name><name><surname>Aoki</surname> <given-names>Y</given-names></name><name><surname>Iwase</surname> <given-names>M</given-names></name><name><surname>Takahashi</surname> <given-names>H</given-names></name><name><surname>Kim</surname> <given-names>M</given-names></name><name><surname>Li</surname> <given-names>Y</given-names></name><name><surname>Jheng</surname> <given-names>HF</given-names></name><name><surname>Nomura</surname> <given-names>W</given-names></name><name><surname>Takahashi</surname> <given-names>N</given-names></name><name><surname>Kim</surname> <given-names>CS</given-names></name><name><surname>Yu</surname> <given-names>R</given-names></name><name><surname>Seno</surname> <given-names>S</given-names></name><name><surname>Matsuda</surname> <given-names>H</given-names></name><name><surname>Aizawa-Abe</surname> <given-names>M</given-names></name><name><surname>Ebihara</surname> <given-names>K</given-names></name><name><surname>Itoh</surname> <given-names>N</given-names></name><name><surname>Kawada</surname> <given-names>T</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>The hepatokine FGF21 is crucial for peroxisome proliferator-activated receptor-α agonist-induced amelioration of metabolic disorders in obese mice</article-title><source>Journal of Biological Chemistry</source><volume>292</volume><fpage>9175</fpage><lpage>9190</lpage><pub-id pub-id-type="doi">10.1074/jbc.M116.767590</pub-id><pub-id pub-id-type="pmid">28404815</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gross</surname> <given-names>JM</given-names></name><name><surname>Dowling</surname> <given-names>JE</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Tbx2b is essential for neuronal differentiation along the dorsal/ventral axis of the zebrafish retina</article-title><source>PNAS</source><volume>102</volume><fpage>4371</fpage><lpage>4376</lpage><pub-id pub-id-type="doi">10.1073/pnas.0501061102</pub-id><pub-id pub-id-type="pmid">15755805</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Han</surname> <given-names>SH</given-names></name><name><surname>Wu</surname> <given-names>MY</given-names></name><name><surname>Nam</surname> <given-names>BY</given-names></name><name><surname>Park</surname> <given-names>JT</given-names></name><name><surname>Yoo</surname> <given-names>TH</given-names></name><name><surname>Kang</surname> <given-names>SW</given-names></name><name><surname>Park</surname> <given-names>J</given-names></name><name><surname>Chinga</surname> <given-names>F</given-names></name><name><surname>Li</surname> <given-names>SY</given-names></name><name><surname>Susztak</surname> <given-names>K</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>PGC-1<italic>α</italic> Protects from Notch-Induced Kidney Fibrosis Development</article-title><source>Journal of the American Society of Nephrology</source><volume>28</volume><fpage>3312</fpage><lpage>3322</lpage><pub-id pub-id-type="doi">10.1681/ASN.2017020130</pub-id><pub-id pub-id-type="pmid">28751525</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hanai</surname> <given-names>J</given-names></name><name><surname>Cao</surname> <given-names>P</given-names></name><name><surname>Tanksale</surname> <given-names>P</given-names></name><name><surname>Imamura</surname> <given-names>S</given-names></name><name><surname>Koshimizu</surname> <given-names>E</given-names></name><name><surname>Zhao</surname> <given-names>J</given-names></name><name><surname>Kishi</surname> <given-names>S</given-names></name><name><surname>Yamashita</surname> <given-names>M</given-names></name><name><surname>Phillips</surname> <given-names>PS</given-names></name><name><surname>Sukhatme</surname> <given-names>VP</given-names></name><name><surname>Lecker</surname> <given-names>SH</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>The muscle-specific ubiquitin ligase atrogin-1/MAFbx mediates statin-induced muscle toxicity</article-title><source>Journal of Clinical Investigation</source><volume>117</volume><fpage>3940</fpage><lpage>3951</lpage><pub-id pub-id-type="doi">10.1172/JCI32741</pub-id><pub-id pub-id-type="pmid">17992259</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Herzig</surname> <given-names>S</given-names></name><name><surname>Long</surname> <given-names>F</given-names></name><name><surname>Jhala</surname> <given-names>US</given-names></name><name><surname>Hedrick</surname> <given-names>S</given-names></name><name><surname>Quinn</surname> <given-names>R</given-names></name><name><surname>Bauer</surname> <given-names>A</given-names></name><name><surname>Rudolph</surname> <given-names>D</given-names></name><name><surname>Schutz</surname> <given-names>G</given-names></name><name><surname>Yoon</surname> <given-names>C</given-names></name><name><surname>Puigserver</surname> <given-names>P</given-names></name><name><surname>Spiegelman</surname> <given-names>B</given-names></name><name><surname>Montminy</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>CREB regulates hepatic gluconeogenesis through the coactivator PGC-1</article-title><source>Nature</source><volume>413</volume><fpage>179</fpage><lpage>183</lpage><pub-id pub-id-type="doi">10.1038/35093131</pub-id><pub-id pub-id-type="pmid">11557984</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jiang</surname> <given-names>H</given-names></name><name><surname>Kang</surname> <given-names>S-U</given-names></name><name><surname>Zhang</surname> <given-names>S</given-names></name><name><surname>Karuppagounder</surname> <given-names>S</given-names></name><name><surname>Xu</surname> <given-names>J</given-names></name><name><surname>Lee</surname> <given-names>Y-K</given-names></name><name><surname>Kang</surname> <given-names>B-G</given-names></name><name><surname>Lee</surname> <given-names>Y</given-names></name><name><surname>Zhang</surname> <given-names>J</given-names></name><name><surname>Pletnikova</surname> <given-names>O</given-names></name><name><surname>Troncoso</surname> <given-names>JC</given-names></name><name><surname>Pirooznia</surname> <given-names>S</given-names></name><name><surname>Andrabi</surname> <given-names>SA</given-names></name><name><surname>Dawson</surname> <given-names>VL</given-names></name><name><surname>Dawson</surname> <given-names>TM</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Adult Conditional Knockout of PGC-1 Leads to Loss of Dopamine Neurons</article-title><source>eNeuro</source><volume>3</volume><elocation-id>piiENEURO.0183-16</elocation-id><pub-id pub-id-type="doi">10.1523/ENEURO.0183-16.2016</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kimmel</surname> <given-names>CB</given-names></name><name><surname>Ballard</surname> <given-names>WW</given-names></name><name><surname>Kimmel</surname> <given-names>SR</given-names></name><name><surname>Ullmann</surname> <given-names>B</given-names></name><name><surname>Schilling</surname> <given-names>TF</given-names></name></person-group><year iso-8601-date="1995">1995</year><article-title>Stages of embryonic development of the zebrafish</article-title><source>Developmental Dynamics</source><volume>203</volume><fpage>253</fpage><lpage>310</lpage><pub-id pub-id-type="doi">10.1002/aja.1002030302</pub-id><pub-id pub-id-type="pmid">8589427</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Knutti</surname> <given-names>D</given-names></name><name><surname>Kralli</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>PGC-1, a versatile coactivator</article-title><source>Trends in Endocrinology &amp; Metabolism</source><volume>12</volume><fpage>360</fpage><lpage>365</lpage><pub-id pub-id-type="doi">10.1016/S1043-2760(01)00457-X</pub-id><pub-id pub-id-type="pmid">11551810</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Krauss</surname> <given-names>S</given-names></name><name><surname>Johansen</surname> <given-names>T</given-names></name><name><surname>Korzh</surname> <given-names>V</given-names></name><name><surname>Fjose</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="1991">1991</year><article-title>Expression of the zebrafish paired box gene pax[zf-b] during early neurogenesis</article-title><source>Development</source><volume>113</volume><fpage>1193</fpage><lpage>1206</lpage><pub-id pub-id-type="pmid">1811936</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kroeger</surname> <given-names>PT</given-names></name><name><surname>Drummond</surname> <given-names>BE</given-names></name><name><surname>Miceli</surname> <given-names>R</given-names></name><name><surname>McKernan</surname> <given-names>M</given-names></name><name><surname>Gerlach</surname> <given-names>GF</given-names></name><name><surname>Marra</surname> <given-names>AN</given-names></name><name><surname>Fox</surname> <given-names>A</given-names></name><name><surname>McCampbell</surname> <given-names>KK</given-names></name><name><surname>Leshchiner</surname> <given-names>I</given-names></name><name><surname>Rodriguez-Mari</surname> <given-names>A</given-names></name><name><surname>BreMiller</surname> <given-names>R</given-names></name><name><surname>Thummel</surname> <given-names>R</given-names></name><name><surname>Davidson</surname> <given-names>AJ</given-names></name><name><surname>Postlethwait</surname> <given-names>J</given-names></name><name><surname>Goessling</surname> <given-names>W</given-names></name><name><surname>Wingert</surname> <given-names>RA</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>The zebrafish kidney mutant zeppelin reveals that brca2/fancd1 is essential for pronephros development</article-title><source>Developmental Biology</source><volume>428</volume><fpage>148</fpage><lpage>163</lpage><pub-id pub-id-type="doi">10.1016/j.ydbio.2017.05.025</pub-id><pub-id pub-id-type="pmid">28579318</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kroeger</surname> <given-names>PT</given-names></name><name><surname>Wingert</surname> <given-names>RA</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Using zebrafish to study podocyte genesis during kidney development and regeneration</article-title><source>Genesis</source><volume>52</volume><fpage>771</fpage><lpage>792</lpage><pub-id pub-id-type="doi">10.1002/dvg.22798</pub-id><pub-id pub-id-type="pmid">24920186</pub-id></element-citation></ref><ref id="bib36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lengerke</surname> <given-names>C</given-names></name><name><surname>Wingert</surname> <given-names>R</given-names></name><name><surname>Beeretz</surname> <given-names>M</given-names></name><name><surname>Grauer</surname> <given-names>M</given-names></name><name><surname>Schmidt</surname> <given-names>AG</given-names></name><name><surname>Konantz</surname> <given-names>M</given-names></name><name><surname>Daley</surname> <given-names>GQ</given-names></name><name><surname>Davidson</surname> <given-names>AJ</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Interactions between Cdx genes and retinoic acid modulate early cardiogenesis</article-title><source>Developmental Biology</source><volume>354</volume><fpage>134</fpage><lpage>142</lpage><pub-id pub-id-type="doi">10.1016/j.ydbio.2011.03.027</pub-id><pub-id pub-id-type="pmid">21466798</pub-id></element-citation></ref><ref id="bib37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname> <given-names>Y</given-names></name><name><surname>Cheng</surname> <given-names>CN</given-names></name><name><surname>Verdun</surname> <given-names>VA</given-names></name><name><surname>Wingert</surname> <given-names>RA</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Zebrafish nephrogenesis is regulated by interactions between retinoic acid, mecom, and Notch signaling</article-title><source>Developmental Biology</source><volume>386</volume><fpage>111</fpage><lpage>122</lpage><pub-id pub-id-type="doi">10.1016/j.ydbio.2013.11.021</pub-id><pub-id pub-id-type="pmid">24309209</pub-id></element-citation></ref><ref id="bib38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liao</surname> <given-names>X</given-names></name><name><surname>Wang</surname> <given-names>Y</given-names></name><name><surname>Wong</surname> <given-names>CW</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Troglitazone induces cytotoxicity in part by promoting the degradation of peroxisome proliferator-activated receptor γ co-activator-1α protein</article-title><source>British Journal of Pharmacology</source><volume>161</volume><fpage>771</fpage><lpage>781</lpage><pub-id pub-id-type="doi">10.1111/j.1476-5381.2010.00900.x</pub-id><pub-id pub-id-type="pmid">20860658</pub-id></element-citation></ref><ref id="bib39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lin</surname> <given-names>J</given-names></name><name><surname>Wu</surname> <given-names>H</given-names></name><name><surname>Tarr</surname> <given-names>PT</given-names></name><name><surname>Zhang</surname> <given-names>CY</given-names></name><name><surname>Wu</surname> <given-names>Z</given-names></name><name><surname>Boss</surname> <given-names>O</given-names></name><name><surname>Michael</surname> <given-names>LF</given-names></name><name><surname>Puigserver</surname> <given-names>P</given-names></name><name><surname>Isotani</surname> <given-names>E</given-names></name><name><surname>Olson</surname> <given-names>EN</given-names></name><name><surname>Lowell</surname> <given-names>BB</given-names></name><name><surname>Bassel-Duby</surname> <given-names>R</given-names></name><name><surname>Spiegelman</surname> <given-names>BM</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>Transcriptional co-activator PGC-1 alpha drives the formation of slow-twitch muscle fibres</article-title><source>Nature</source><volume>418</volume><fpage>797</fpage><lpage>801</lpage><pub-id pub-id-type="doi">10.1038/nature00904</pub-id><pub-id pub-id-type="pmid">12181572</pub-id></element-citation></ref><ref id="bib40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lin</surname> <given-names>J</given-names></name><name><surname>Handschin</surname> <given-names>C</given-names></name><name><surname>Spiegelman</surname> <given-names>BM</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Metabolic control through the PGC-1 family of transcription coactivators</article-title><source>Cell Metabolism</source><volume>1</volume><fpage>361</fpage><lpage>370</lpage><pub-id pub-id-type="doi">10.1016/j.cmet.2005.05.004</pub-id><pub-id pub-id-type="pmid">16054085</pub-id></element-citation></ref><ref id="bib41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lindström</surname> <given-names>NO</given-names></name><name><surname>Lawrence</surname> <given-names>ML</given-names></name><name><surname>Burn</surname> <given-names>SF</given-names></name><name><surname>Johansson</surname> <given-names>JA</given-names></name><name><surname>Bakker</surname> <given-names>ER</given-names></name><name><surname>Ridgway</surname> <given-names>RA</given-names></name><name><surname>Chang</surname> <given-names>CH</given-names></name><name><surname>Karolak</surname> <given-names>MJ</given-names></name><name><surname>Oxburgh</surname> <given-names>L</given-names></name><name><surname>Headon</surname> <given-names>DJ</given-names></name><name><surname>Sansom</surname> <given-names>OJ</given-names></name><name><surname>Smits</surname> <given-names>R</given-names></name><name><surname>Davies</surname> <given-names>JA</given-names></name><name><surname>Hohenstein</surname> <given-names>P</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Integrated β-catenin, BMP, PTEN, and Notch signalling patterns the nephron</article-title><source>eLife</source><volume>3</volume><elocation-id>e04000</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.04000</pub-id><pub-id pub-id-type="pmid">25647637</pub-id></element-citation></ref><ref id="bib42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lindström</surname> <given-names>NO</given-names></name><name><surname>McMahon</surname> <given-names>JA</given-names></name><name><surname>Guo</surname> <given-names>J</given-names></name><name><surname>Tran</surname> <given-names>T</given-names></name><name><surname>Guo</surname> <given-names>Q</given-names></name><name><surname>Rutledge</surname> <given-names>E</given-names></name><name><surname>Parvez</surname> <given-names>RK</given-names></name><name><surname>Saribekyan</surname> <given-names>G</given-names></name><name><surname>Schuler</surname> <given-names>RE</given-names></name><name><surname>Liao</surname> <given-names>C</given-names></name><name><surname>Kim</surname> <given-names>AD</given-names></name><name><surname>Abdelhalim</surname> <given-names>A</given-names></name><name><surname>Ruffins</surname> <given-names>SW</given-names></name><name><surname>Thornton</surname> <given-names>ME</given-names></name><name><surname>Basking</surname> <given-names>L</given-names></name><name><surname>Grubbs</surname> <given-names>B</given-names></name><name><surname>Kesselman</surname> <given-names>C</given-names></name><name><surname>McMahon</surname> <given-names>AP</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Conserved and Divergent Features of Human and Mouse Kidney Organogenesis</article-title><source>Journal of the American Society of Nephrology</source><volume>29</volume><elocation-id>ASN.2017080887</elocation-id><pub-id pub-id-type="doi">10.1681/ASN.2017080887</pub-id></element-citation></ref><ref id="bib43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Löhr</surname> <given-names>H</given-names></name><name><surname>Ryu</surname> <given-names>S</given-names></name><name><surname>Driever</surname> <given-names>W</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Zebrafish diencephalic A11-related dopaminergic neurons share a conserved transcriptional network with neuroendocrine cell lineages</article-title><source>Development</source><volume>136</volume><fpage>1007</fpage><lpage>1017</lpage><pub-id pub-id-type="doi">10.1242/dev.033878</pub-id><pub-id pub-id-type="pmid">19234064</pub-id></element-citation></ref><ref id="bib44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lynch</surname> <given-names>MR</given-names></name><name><surname>Tran</surname> <given-names>MT</given-names></name><name><surname>Parikh</surname> <given-names>SM</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>PGC1α in the kidney</article-title><source>American Journal of Physiology-Renal Physiology</source><volume>314</volume><fpage>F1</fpage><lpage>F8</lpage><pub-id pub-id-type="doi">10.1152/ajprenal.00263.2017</pub-id><pub-id pub-id-type="pmid">28931521</pub-id></element-citation></ref><ref id="bib45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marra</surname> <given-names>AN</given-names></name><name><surname>Li</surname> <given-names>Y</given-names></name><name><surname>Wingert</surname> <given-names>RA</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Antennas of organ morphogenesis: the roles of cilia in vertebrate kidney development</article-title><source>Genesis</source><volume>54</volume><fpage>457</fpage><lpage>469</lpage><pub-id pub-id-type="doi">10.1002/dvg.22957</pub-id><pub-id pub-id-type="pmid">27389733</pub-id></element-citation></ref><ref id="bib46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marra</surname> <given-names>AN</given-names></name><name><surname>Ulrich</surname> <given-names>M</given-names></name><name><surname>White</surname> <given-names>A</given-names></name><name><surname>Springer</surname> <given-names>M</given-names></name><name><surname>Wingert</surname> <given-names>RA</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Visualizing multiciliated cells in the zebrafish through a combined protocol of whole mount fluorescent in situ hybridization and immunofluorescence</article-title><source>Journal of Visualized Experiments</source><volume>129</volume><elocation-id>e56261</elocation-id><pub-id pub-id-type="doi">10.3791/56261</pub-id></element-citation></ref><ref id="bib47"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marra</surname> <given-names>AN</given-names></name><name><surname>Wingert</surname> <given-names>RA</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Epithelial cell fate in the nephron tubule is mediated by the ETS transcription factors etv5a and etv4 during zebrafish kidney development</article-title><source>Developmental Biology</source><volume>411</volume><fpage>231</fpage><lpage>245</lpage><pub-id pub-id-type="doi">10.1016/j.ydbio.2016.01.035</pub-id><pub-id pub-id-type="pmid">26827902</pub-id></element-citation></ref><ref id="bib48"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McCampbell</surname> <given-names>KK</given-names></name><name><surname>Springer</surname> <given-names>KN</given-names></name><name><surname>Wingert</surname> <given-names>RA</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Analysis of nephron composition and function in the adult zebrafish kidney</article-title><source>Journal of Visualized Experiments</source><volume>90</volume><fpage>e51644</fpage><pub-id pub-id-type="doi">10.3791/51644</pub-id><pub-id pub-id-type="pmid">25145398</pub-id></element-citation></ref><ref id="bib49"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McCampbell</surname> <given-names>KK</given-names></name><name><surname>Springer</surname> <given-names>KN</given-names></name><name><surname>Wingert</surname> <given-names>RA</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Atlas of Cellular Dynamics during Zebrafish Adult Kidney Regeneration</article-title><source>Stem Cells International</source><volume>2015</volume><fpage>1</fpage><lpage>19</lpage><pub-id pub-id-type="doi">10.1155/2015/547636</pub-id></element-citation></ref><ref id="bib50"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McCampbell</surname> <given-names>KK</given-names></name><name><surname>Wingert</surname> <given-names>RA</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>New tides: using zebrafish to study renal regeneration</article-title><source>Translational Research</source><volume>163</volume><fpage>109</fpage><lpage>122</lpage><pub-id pub-id-type="doi">10.1016/j.trsl.2013.10.003</pub-id><pub-id pub-id-type="pmid">24183931</pub-id></element-citation></ref><ref id="bib51"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McKee</surname> <given-names>R</given-names></name><name><surname>Gerlach</surname> <given-names>GF</given-names></name><name><surname>Jou</surname> <given-names>J</given-names></name><name><surname>Cheng</surname> <given-names>CN</given-names></name><name><surname>Wingert</surname> <given-names>RA</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Temporal and spatial expression of tight junction genes during zebrafish pronephros development</article-title><source>Gene Expression Patterns</source><volume>16</volume><fpage>104</fpage><lpage>113</lpage><pub-id pub-id-type="doi">10.1016/j.gep.2014.11.001</pub-id><pub-id pub-id-type="pmid">25460834</pub-id></element-citation></ref><ref id="bib52"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Morales</surname> <given-names>EE</given-names></name><name><surname>Handa</surname> <given-names>N</given-names></name><name><surname>Drummond</surname> <given-names>BE</given-names></name><name><surname>Chambers</surname> <given-names>JM</given-names></name><name><surname>Marra</surname> <given-names>AN</given-names></name><name><surname>Addiego</surname> <given-names>A</given-names></name><name><surname>Wingert</surname> <given-names>RA</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Homeogene emx1 is required for nephron distal segment development in zebrafish</article-title><source>Scientific Reports</source><pub-id pub-id-type="doi">10.1038/s41598-018-36061-4</pub-id></element-citation></ref><ref id="bib53"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Naylor</surname> <given-names>RW</given-names></name><name><surname>Dodd</surname> <given-names>RC</given-names></name><name><surname>Davidson</surname> <given-names>AJ</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Caudal migration and proliferation of renal progenitors regulates early nephron segment size in zebrafish</article-title><source>Scientific Reports</source><volume>6</volume><elocation-id>35647</elocation-id><pub-id pub-id-type="doi">10.1038/srep35647</pub-id><pub-id pub-id-type="pmid">27759103</pub-id></element-citation></ref><ref id="bib54"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nissim</surname> <given-names>S</given-names></name><name><surname>Sherwood</surname> <given-names>RI</given-names></name><name><surname>Wucherpfennig</surname> <given-names>J</given-names></name><name><surname>Saunders</surname> <given-names>D</given-names></name><name><surname>Harris</surname> <given-names>JM</given-names></name><name><surname>Esain</surname> <given-names>V</given-names></name><name><surname>Carroll</surname> <given-names>KJ</given-names></name><name><surname>Frechette</surname> <given-names>GM</given-names></name><name><surname>Kim</surname> <given-names>AJ</given-names></name><name><surname>Hwang</surname> <given-names>KL</given-names></name><name><surname>Cutting</surname> <given-names>CC</given-names></name><name><surname>Elledge</surname> <given-names>S</given-names></name><name><surname>North</surname> <given-names>TE</given-names></name><name><surname>Goessling</surname> <given-names>W</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Prostaglandin E2 regulates liver versus pancreas cell-fate decisions and endodermal outgrowth</article-title><source>Developmental Cell</source><volume>28</volume><fpage>423</fpage><lpage>437</lpage><pub-id pub-id-type="doi">10.1016/j.devcel.2014.01.006</pub-id><pub-id pub-id-type="pmid">24530296</pub-id></element-citation></ref><ref id="bib55"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>North</surname> <given-names>TE</given-names></name><name><surname>Goessling</surname> <given-names>W</given-names></name><name><surname>Walkley</surname> <given-names>CR</given-names></name><name><surname>Lengerke</surname> <given-names>C</given-names></name><name><surname>Kopani</surname> <given-names>KR</given-names></name><name><surname>Lord</surname> <given-names>AM</given-names></name><name><surname>Weber</surname> <given-names>GJ</given-names></name><name><surname>Bowman</surname> <given-names>TV</given-names></name><name><surname>Jang</surname> <given-names>IH</given-names></name><name><surname>Grosser</surname> <given-names>T</given-names></name><name><surname>Fitzgerald</surname> <given-names>GA</given-names></name><name><surname>Daley</surname> <given-names>GQ</given-names></name><name><surname>Orkin</surname> <given-names>SH</given-names></name><name><surname>Zon</surname> <given-names>LI</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Prostaglandin E2 regulates vertebrate haematopoietic stem cell homeostasis</article-title><source>Nature</source><volume>447</volume><fpage>1007</fpage><lpage>1011</lpage><pub-id pub-id-type="doi">10.1038/nature05883</pub-id><pub-id pub-id-type="pmid">17581586</pub-id></element-citation></ref><ref id="bib56"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>O'Brien</surname> <given-names>LL</given-names></name><name><surname>Grimaldi</surname> <given-names>M</given-names></name><name><surname>Kostun</surname> <given-names>Z</given-names></name><name><surname>Wingert</surname> <given-names>RA</given-names></name><name><surname>Selleck</surname> <given-names>R</given-names></name><name><surname>Davidson</surname> <given-names>AJ</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Wt1a, Foxc1a, and the Notch mediator Rbpj physically interact and regulate the formation of podocytes in zebrafish</article-title><source>Developmental Biology</source><volume>358</volume><fpage>318</fpage><lpage>330</lpage><pub-id pub-id-type="doi">10.1016/j.ydbio.2011.08.005</pub-id><pub-id pub-id-type="pmid">21871448</pub-id></element-citation></ref><ref id="bib57"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pagliarini</surname> <given-names>DJ</given-names></name><name><surname>Calvo</surname> <given-names>SE</given-names></name><name><surname>Chang</surname> <given-names>B</given-names></name><name><surname>Sheth</surname> <given-names>SA</given-names></name><name><surname>Vafai</surname> <given-names>SB</given-names></name><name><surname>Ong</surname> <given-names>SE</given-names></name><name><surname>Walford</surname> <given-names>GA</given-names></name><name><surname>Sugiana</surname> <given-names>C</given-names></name><name><surname>Boneh</surname> <given-names>A</given-names></name><name><surname>Chen</surname> <given-names>WK</given-names></name><name><surname>Hill</surname> <given-names>DE</given-names></name><name><surname>Vidal</surname> <given-names>M</given-names></name><name><surname>Evans</surname> <given-names>JG</given-names></name><name><surname>Thorburn</surname> <given-names>DR</given-names></name><name><surname>Carr</surname> <given-names>SA</given-names></name><name><surname>Mootha</surname> <given-names>VK</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>A mitochondrial protein compendium elucidates complex I disease biology</article-title><source>Cell</source><volume>134</volume><fpage>112</fpage><lpage>123</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2008.06.016</pub-id><pub-id pub-id-type="pmid">18614015</pub-id></element-citation></ref><ref id="bib58"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pardo</surname> <given-names>R</given-names></name><name><surname>Enguix</surname> <given-names>N</given-names></name><name><surname>Lasheras</surname> <given-names>J</given-names></name><name><surname>Feliu</surname> <given-names>JE</given-names></name><name><surname>Kralli</surname> <given-names>A</given-names></name><name><surname>Villena</surname> <given-names>JA</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Rosiglitazone-induced mitochondrial biogenesis in white adipose tissue is independent of peroxisome proliferator-activated receptor γ coactivator-1α</article-title><source>PLoS One</source><volume>6</volume><elocation-id>e26989</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0026989</pub-id><pub-id pub-id-type="pmid">22087241</pub-id></element-citation></ref><ref id="bib59"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Patten</surname> <given-names>IS</given-names></name><name><surname>Rana</surname> <given-names>S</given-names></name><name><surname>Shahul</surname> <given-names>S</given-names></name><name><surname>Rowe</surname> <given-names>GC</given-names></name><name><surname>Jang</surname> <given-names>C</given-names></name><name><surname>Liu</surname> <given-names>L</given-names></name><name><surname>Hacker</surname> <given-names>MR</given-names></name><name><surname>Rhee</surname> <given-names>JS</given-names></name><name><surname>Mitchell</surname> <given-names>J</given-names></name><name><surname>Mahmood</surname> <given-names>F</given-names></name><name><surname>Hess</surname> <given-names>P</given-names></name><name><surname>Farrell</surname> <given-names>C</given-names></name><name><surname>Koulisis</surname> <given-names>N</given-names></name><name><surname>Khankin</surname> <given-names>EV</given-names></name><name><surname>Burke</surname> <given-names>SD</given-names></name><name><surname>Tudorache</surname> <given-names>I</given-names></name><name><surname>Bauersachs</surname> <given-names>J</given-names></name><name><surname>del Monte</surname> <given-names>F</given-names></name><name><surname>Hilfiker-Kleiner</surname> <given-names>D</given-names></name><name><surname>Karumanchi</surname> <given-names>SA</given-names></name><name><surname>Arany</surname> <given-names>Z</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Cardiac angiogenic imbalance leads to peripartum cardiomyopathy</article-title><source>Nature</source><volume>485</volume><fpage>333</fpage><lpage>338</lpage><pub-id pub-id-type="doi">10.1038/nature11040</pub-id><pub-id pub-id-type="pmid">22596155</pub-id></element-citation></ref><ref id="bib60"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Poureetezadi</surname> <given-names>SJ</given-names></name><name><surname>Donahue</surname> <given-names>EK</given-names></name><name><surname>Wingert</surname> <given-names>RA</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>A manual small molecule screen approaching high-throughput using zebrafish embryos</article-title><source>Journal of Visualized Experiments</source><volume>93</volume><elocation-id>e52063</elocation-id><pub-id pub-id-type="doi">10.3791/52063</pub-id></element-citation></ref><ref id="bib61"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Poureetezadi</surname> <given-names>SJ</given-names></name><name><surname>Cheng</surname> <given-names>CN</given-names></name><name><surname>Chambers</surname> <given-names>JM</given-names></name><name><surname>Drummond</surname> <given-names>BE</given-names></name><name><surname>Wingert</surname> <given-names>RA</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Prostaglandin signaling regulates nephron segment patterning of renal progenitors during zebrafish kidney development</article-title><source>eLife</source><volume>5</volume><elocation-id>e17551</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.17551</pub-id><pub-id pub-id-type="pmid">27996936</pub-id></element-citation></ref><ref id="bib62"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Poureetezadi</surname> <given-names>SJ</given-names></name><name><surname>Wingert</surname> <given-names>RA</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Little fish, big catch: zebrafish as a model for kidney disease</article-title><source>Kidney International</source><volume>89</volume><fpage>1204</fpage><lpage>1210</lpage><pub-id pub-id-type="doi">10.1016/j.kint.2016.01.031</pub-id><pub-id pub-id-type="pmid">27165832</pub-id></element-citation></ref><ref id="bib63"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Puigserver</surname> <given-names>P</given-names></name><name><surname>Wu</surname> <given-names>Z</given-names></name><name><surname>Park</surname> <given-names>CW</given-names></name><name><surname>Graves</surname> <given-names>R</given-names></name><name><surname>Wright</surname> <given-names>M</given-names></name><name><surname>Spiegelman</surname> <given-names>BM</given-names></name></person-group><year iso-8601-date="1998">1998</year><article-title>A cold-inducible coactivator of nuclear receptors linked to adaptive thermogenesis</article-title><source>Cell</source><volume>92</volume><fpage>829</fpage><lpage>839</lpage><pub-id pub-id-type="doi">10.1016/S0092-8674(00)81410-5</pub-id><pub-id pub-id-type="pmid">9529258</pub-id></element-citation></ref><ref id="bib64"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Puigserver</surname> <given-names>P</given-names></name><name><surname>Adelmant</surname> <given-names>G</given-names></name><name><surname>Wu</surname> <given-names>Z</given-names></name><name><surname>Fan</surname> <given-names>M</given-names></name><name><surname>Xu</surname> <given-names>J</given-names></name><name><surname>O'Malley</surname> <given-names>B</given-names></name><name><surname>Spiegelman</surname> <given-names>BM</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>Activation of PPARgamma coactivator-1 through transcription factor docking</article-title><source>Science</source><volume>286</volume><fpage>1368</fpage><lpage>1371</lpage><pub-id pub-id-type="doi">10.1126/science.286.5443.1368</pub-id><pub-id pub-id-type="pmid">10558993</pub-id></element-citation></ref><ref id="bib65"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Puigserver</surname> <given-names>P</given-names></name><name><surname>Spiegelman</surname> <given-names>BM</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Peroxisome proliferator-activated receptor-gamma coactivator 1 alpha (PGC-1 alpha): transcriptional coactivator and metabolic regulator</article-title><source>Endocrine Reviews</source><volume>24</volume><fpage>78</fpage><lpage>90</lpage><pub-id pub-id-type="doi">10.1210/er.2002-0012</pub-id><pub-id pub-id-type="pmid">12588810</pub-id></element-citation></ref><ref id="bib66"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Püschel</surname> <given-names>AW</given-names></name><name><surname>Westerfield</surname> <given-names>M</given-names></name><name><surname>Dressler</surname> <given-names>GR</given-names></name></person-group><year iso-8601-date="1992">1992</year><article-title>Comparative analysis of Pax-2 protein distributions during neurulation in mice and zebrafish</article-title><source>Mechanisms of Development</source><volume>38</volume><fpage>197</fpage><lpage>208</lpage><pub-id pub-id-type="doi">10.1016/0925-4773(92)90053-M</pub-id><pub-id pub-id-type="pmid">1457381</pub-id></element-citation></ref><ref id="bib67"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Romagnani</surname> <given-names>P</given-names></name><name><surname>Lasagni</surname> <given-names>L</given-names></name><name><surname>Remuzzi</surname> <given-names>G</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Renal progenitors: an evolutionary conserved strategy for kidney regeneration</article-title><source>Nature Reviews Nephrology</source><volume>9</volume><fpage>137</fpage><lpage>146</lpage><pub-id pub-id-type="doi">10.1038/nrneph.2012.290</pub-id><pub-id pub-id-type="pmid">23338209</pub-id></element-citation></ref><ref id="bib68"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Russell</surname> <given-names>LK</given-names></name><name><surname>Mansfield</surname> <given-names>CM</given-names></name><name><surname>Lehman</surname> <given-names>JJ</given-names></name><name><surname>Kovacs</surname> <given-names>A</given-names></name><name><surname>Courtois</surname> <given-names>M</given-names></name><name><surname>Saffitz</surname> <given-names>JE</given-names></name><name><surname>Medeiros</surname> <given-names>DM</given-names></name><name><surname>Valencik</surname> <given-names>ML</given-names></name><name><surname>McDonald</surname> <given-names>JA</given-names></name><name><surname>Kelly</surname> <given-names>DP</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Cardiac-specific induction of the transcriptional coactivator peroxisome proliferator-activated receptor gamma coactivator-1alpha promotes mitochondrial biogenesis and reversible cardiomyopathy in a developmental stage-dependent manner</article-title><source>Circulation Research</source><volume>94</volume><fpage>525</fpage><lpage>533</lpage><pub-id pub-id-type="doi">10.1161/01.RES.0000117088.36577.EB</pub-id><pub-id pub-id-type="pmid">14726475</pub-id></element-citation></ref><ref id="bib69"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saint-Geniez</surname> <given-names>M</given-names></name><name><surname>Jiang</surname> <given-names>A</given-names></name><name><surname>Abend</surname> <given-names>S</given-names></name><name><surname>Liu</surname> <given-names>L</given-names></name><name><surname>Sweigard</surname> <given-names>H</given-names></name><name><surname>Connor</surname> <given-names>KM</given-names></name><name><surname>Arany</surname> <given-names>Z</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>PGC-1α regulates normal and pathological angiogenesis in the retina</article-title><source>The American Journal of Pathology</source><volume>182</volume><fpage>255</fpage><lpage>265</lpage><pub-id pub-id-type="doi">10.1016/j.ajpath.2012.09.003</pub-id><pub-id pub-id-type="pmid">23141926</pub-id></element-citation></ref><ref id="bib70"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sanoudou</surname> <given-names>D</given-names></name><name><surname>Duka</surname> <given-names>A</given-names></name><name><surname>Drosatos</surname> <given-names>K</given-names></name><name><surname>Hayes</surname> <given-names>KC</given-names></name><name><surname>Zannis</surname> <given-names>VI</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Role of Esrrg in the fibrate-mediated regulation of lipid metabolism genes in human ApoA-I transgenic mice</article-title><source>The Pharmacogenomics Journal</source><volume>10</volume><fpage>165</fpage><lpage>179</lpage><pub-id pub-id-type="doi">10.1038/tpj.2009.51</pub-id><pub-id pub-id-type="pmid">19949424</pub-id></element-citation></ref><ref id="bib71"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saxén</surname> <given-names>L</given-names></name><name><surname>Sariola</surname> <given-names>H</given-names></name></person-group><year iso-8601-date="1987">1987</year><article-title>Early organogenesis of the kidney</article-title><source>Pediatric Nephrology</source><volume>1</volume><fpage>385</fpage><lpage>392</lpage><pub-id pub-id-type="doi">10.1007/BF00849241</pub-id><pub-id pub-id-type="pmid">3153305</pub-id></element-citation></ref><ref id="bib72"><element-citation publication-type="data"><person-group person-group-type="author"><name><surname>Thisse</surname> <given-names>C</given-names></name><name><surname>Thisse</surname> <given-names>B</given-names></name></person-group><year iso-8601-date="2008">2008</year><data-title>Expression from: unexpected novel relational links uncovered by extensive developmental profiling of nuclear receptor expression</data-title><source>ZFIN Direct Data Submission</source><pub-id pub-id-type="archive" xlink:href="https://www.zfin.org/ZDB-PUB-080220-1">ZDB-PUB-080220-1</pub-id></element-citation></ref><ref id="bib73"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tran</surname> <given-names>M</given-names></name><name><surname>Tam</surname> <given-names>D</given-names></name><name><surname>Bardia</surname> <given-names>A</given-names></name><name><surname>Bhasin</surname> <given-names>M</given-names></name><name><surname>Rowe</surname> <given-names>GC</given-names></name><name><surname>Kher</surname> <given-names>A</given-names></name><name><surname>Zsengeller</surname> <given-names>ZK</given-names></name><name><surname>Akhavan-Sharif</surname> <given-names>MR</given-names></name><name><surname>Khankin</surname> <given-names>EV</given-names></name><name><surname>Saintgeniez</surname> <given-names>M</given-names></name><name><surname>David</surname> <given-names>S</given-names></name><name><surname>Burstein</surname> <given-names>D</given-names></name><name><surname>Karumanchi</surname> <given-names>SA</given-names></name><name><surname>Stillman</surname> <given-names>IE</given-names></name><name><surname>Arany</surname> <given-names>Z</given-names></name><name><surname>Parikh</surname> <given-names>SM</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>PGC-1α promotes recovery after acute kidney injury during systemic inflammation in mice</article-title><source>Journal of Clinical Investigation</source><volume>121</volume><fpage>4003</fpage><lpage>4014</lpage><pub-id pub-id-type="doi">10.1172/JCI58662</pub-id><pub-id pub-id-type="pmid">21881206</pub-id></element-citation></ref><ref id="bib74"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tran</surname> <given-names>MT</given-names></name><name><surname>Zsengeller</surname> <given-names>ZK</given-names></name><name><surname>Berg</surname> <given-names>AH</given-names></name><name><surname>Khankin</surname> <given-names>EV</given-names></name><name><surname>Bhasin</surname> <given-names>MK</given-names></name><name><surname>Kim</surname> <given-names>W</given-names></name><name><surname>Clish</surname> <given-names>CB</given-names></name><name><surname>Stillman</surname> <given-names>IE</given-names></name><name><surname>Karumanchi</surname> <given-names>SA</given-names></name><name><surname>Rhee</surname> <given-names>EP</given-names></name><name><surname>Parikh</surname> <given-names>SM</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>PGC1α drives NAD biosynthesis linking oxidative metabolism to renal protection</article-title><source>Nature</source><volume>531</volume><fpage>528</fpage><lpage>532</lpage><pub-id pub-id-type="doi">10.1038/nature17184</pub-id><pub-id pub-id-type="pmid">26982719</pub-id></element-citation></ref><ref id="bib75"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname> <given-names>X</given-names></name><name><surname>Moraes</surname> <given-names>CT</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Increases in mitochondrial biogenesis impair carcinogenesis at multiple levels</article-title><source>Molecular Oncology</source><volume>5</volume><fpage>399</fpage><lpage>409</lpage><pub-id pub-id-type="doi">10.1016/j.molonc.2011.07.008</pub-id><pub-id pub-id-type="pmid">21855427</pub-id></element-citation></ref><ref id="bib76"><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Westerfield</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="1993">1993</year><source>The Zebrafish Book</source><publisher-loc>Eugene</publisher-loc><publisher-name>University of Oregon Press</publisher-name></element-citation></ref><ref id="bib77"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wingert</surname> <given-names>RA</given-names></name><name><surname>Selleck</surname> <given-names>R</given-names></name><name><surname>Yu</surname> <given-names>J</given-names></name><name><surname>Song</surname> <given-names>H-D</given-names></name><name><surname>Chen</surname> <given-names>Z</given-names></name><name><surname>Song</surname> <given-names>A</given-names></name><name><surname>Zhou</surname> <given-names>Y</given-names></name><name><surname>Thisse</surname> <given-names>B</given-names></name><name><surname>Thisse</surname> <given-names>C</given-names></name><name><surname>McMahon</surname> <given-names>AP</given-names></name><name><surname>Davidson</surname> <given-names>AJ</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>The cdx genes and retinoic acid control the positioning and segmentation of the zebrafish pronephros</article-title><source>PLoS Genetics</source><volume>3</volume><elocation-id>e189</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pgen.0030189</pub-id></element-citation></ref><ref id="bib78"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wingert</surname> <given-names>RA</given-names></name><name><surname>Davidson</surname> <given-names>AJ</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>The zebrafish pronephros: a model to study nephron segmentation</article-title><source>Kidney International</source><volume>73</volume><fpage>1120</fpage><lpage>1127</lpage><pub-id pub-id-type="doi">10.1038/ki.2008.37</pub-id><pub-id pub-id-type="pmid">18322540</pub-id></element-citation></ref><ref id="bib79"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wingert</surname> <given-names>RA</given-names></name><name><surname>Davidson</surname> <given-names>AJ</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Zebrafish nephrogenesis involves dynamic spatiotemporal expression changes in renal progenitors and essential signals from retinoic acid and irx3b</article-title><source>Developmental Dynamics</source><volume>240</volume><fpage>2011</fpage><lpage>2027</lpage><pub-id pub-id-type="doi">10.1002/dvdy.22691</pub-id><pub-id pub-id-type="pmid">21761484</pub-id></element-citation></ref><ref id="bib80"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname> <given-names>Z</given-names></name><name><surname>Puigserver</surname> <given-names>P</given-names></name><name><surname>Andersson</surname> <given-names>U</given-names></name><name><surname>Zhang</surname> <given-names>C</given-names></name><name><surname>Adelmant</surname> <given-names>G</given-names></name><name><surname>Mootha</surname> <given-names>V</given-names></name><name><surname>Troy</surname> <given-names>A</given-names></name><name><surname>Cinti</surname> <given-names>S</given-names></name><name><surname>Lowell</surname> <given-names>B</given-names></name><name><surname>Scarpulla</surname> <given-names>RC</given-names></name><name><surname>Spiegelman</surname> <given-names>BM</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>Mechanisms controlling mitochondrial biogenesis and respiration through the thermogenic coactivator PGC-1</article-title><source>Cell</source><volume>98</volume><fpage>115</fpage><lpage>124</lpage><pub-id pub-id-type="doi">10.1016/S0092-8674(00)80611-X</pub-id><pub-id pub-id-type="pmid">10412986</pub-id></element-citation></ref><ref id="bib81"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yoon</surname> <given-names>JC</given-names></name><name><surname>Puigserver</surname> <given-names>P</given-names></name><name><surname>Chen</surname> <given-names>G</given-names></name><name><surname>Donovan</surname> <given-names>J</given-names></name><name><surname>Wu</surname> <given-names>Z</given-names></name><name><surname>Rhee</surname> <given-names>J</given-names></name><name><surname>Adelmant</surname> <given-names>G</given-names></name><name><surname>Stafford</surname> <given-names>J</given-names></name><name><surname>Kahn</surname> <given-names>CR</given-names></name><name><surname>Granner</surname> <given-names>DK</given-names></name><name><surname>Newgard</surname> <given-names>CB</given-names></name><name><surname>Spiegelman</surname> <given-names>BM</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>Control of hepatic gluconeogenesis through the transcriptional coactivator PGC-1</article-title><source>Nature</source><volume>413</volume><fpage>131</fpage><lpage>138</lpage><pub-id pub-id-type="doi">10.1038/35093050</pub-id><pub-id pub-id-type="pmid">11557972</pub-id></element-citation></ref><ref id="bib82"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yu</surname> <given-names>B</given-names></name><name><surname>Huo</surname> <given-names>L</given-names></name><name><surname>Liu</surname> <given-names>Y</given-names></name><name><surname>Deng</surname> <given-names>P</given-names></name><name><surname>Szymanski</surname> <given-names>J</given-names></name><name><surname>Li</surname> <given-names>J</given-names></name><name><surname>Luo</surname> <given-names>X</given-names></name><name><surname>Hong</surname> <given-names>C</given-names></name><name><surname>Lin</surname> <given-names>J</given-names></name><name><surname>Wang</surname> <given-names>C-Y</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>PGC-1α controls skeletal stem cell fate and bone-fat balance in osteoporosis and skeletal aging by inducing TAZ</article-title><source>Cell Stem Cell</source><volume>23</volume><fpage>193</fpage><lpage>209</lpage><pub-id pub-id-type="doi">10.1016/j.stem.2018.06.009</pub-id></element-citation></ref></ref-list></back><sub-article article-type="decision-letter" id="SA1"><front-stub><article-id pub-id-type="doi">10.7554/eLife.40266.026</article-id><title-group><article-title>Decision letter</article-title></title-group><contrib-group><contrib contrib-type="editor"><name><surname>Whitfield</surname><given-names>Tanya T</given-names></name><role>Reviewing Editor</role><aff><institution>University of Sheffield</institution><country>United Kingdom</country></aff></contrib></contrib-group></front-stub><body><boxed-text><p>In the interests of transparency, eLife includes the editorial decision letter and accompanying author responses. A lightly edited version of the letter sent to the authors after peer review is shown, indicating the most substantive concerns; minor comments are not usually included.</p></boxed-text><p>Thank you for submitting your article &quot;<italic>ppargc1a</italic> controls nephron segmentation during zebrafish embryonic kidney ontogeny&quot; for consideration by <italic>eLife</italic>. Your article has been reviewed by two peer reviewers, and the evaluation has been overseen by Tanya Whitfield as the Reviewing Editor and Sean Morrison as the Senior Editor. The following individual involved in review of your submission has agreed to reveal his identity: Dirk Meyer (Reviewer #2).</p><p>The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission.</p><p>Summary:</p><p>The manuscript by Chambers et al. describes a novel role of the transcriptional coactivator Ppargc1a/PGC-1α in embryonic zebrafish pronephros patterning and segmentation. The experiments build on results of an earlier small compound screen from the same lab in which PPAR agonists were found to interfere with nephron patterning. In this manuscript experiments are described that present <italic>ppargc1a</italic> as a promising candidate involved in mediating the underlying patterning activities. By combining genetic, morpholino and RNA-injection based functional approaches with WISH-based phenotype analyses the authors show that <italic>ppargc1a</italic> is involved in nephron pattering and they reveal evidence for interactions between <italic>ppargc1a, tbx2b</italic> and <italic>sim1a</italic> in the proper positioning of distal pronephric segment boundaries.</p><p>Essential revisions:</p><p>Both reviewers are positive about the work, but both suggest revisions, some of which are overlapping.</p><p>1) Please use qRT-PCR to quantify the expression changes detailed in the manuscript (a suggestion of both reviewers).</p><p>2) Please revise the arguments about epistasis so that they refer to the comparison of double and single mutant phenotypes and not expression analysis in a single mutant, as suggested by reviewer 1.</p><p>3) Provide more data on the initial screen (reviewer 2).</p><p>4) Include a more comprehensive study of cell proliferation and cell death (reviewer 2).</p><p>5) Test for cross-repressive interactions by RNA overexpression (reviewer 2).</p><p>For further information, the full reviews are appended below.</p><p><italic>Reviewer #1:</italic> </p><p>This study offers a significant advance in delineating the genetic hierarchies that regulate nephron segment patterning during zebrafish development. The authors follow up on their earlier work, in which through unbiased small molecule screens, they identified PPAR signaling as a candidate pathway for regulating this process. Here, the authors show that <italic>ppargca1</italic> encoding PPAR coactivator is expressed in intermediate mesoderm in early zebrafish embryos and this expression is dynamic in the course of kidney development. Through a combination of various single and compound loss and gain of function approaches, the authors place <italic>ppargc1a</italic> upstream of <italic>tbx2b</italic> in promoting distal segment formation and discover mutually antagonistic regulatory relationship between <italic>ppargc1a</italic> and <italic>sim1a</italic> in establishment of the proximal straight tubule (PST) segment boundaries. However, because loss of PST markers is suppressed by <italic>ppargc1a</italic> deficiency, with the compound deficiency presenting with a normal PST pattern, this work implies that a redundant patterning mechanism must be at work. Given the conservation of kidney segment patterning processes across vertebrates, these relationships are likely to inform and be conserved in other animals. The work is in general compelling and data very well and clearly presented. Therefore, this work should be of interest to the broad developmental and regenerative biology community. However, some of the conclusions need additional experimental support and some interpretations of the results need to be revised, before the manuscript becomes suitable for publication.</p><p>– The conclusion that bezafibrate treatment affects <italic>ppargc1a</italic> expression is not compelling and requires further experimental analysis. Currently, expression of <italic>ppargc1a</italic> is analyzed in the drug treated embryos during late segmentation (28S – the stage is not provided on the Figure 2 or in the text) and reduced expression domain is observed. However, by this stage as shown in Figure 1, <italic>ppargc1a</italic> expression is limited to the cells that express the distal segment markers. Therefore, that <italic>ppargc1a</italic> expression domain is reduced could simply reflect that DL is reduced what is the key finding of the manuscript. The authors also note that expression level of <italic>ppargc1a</italic> RNA appears reduced, but WISH is not a quantitative method. Therefore, it would be important to analyze <italic>ppargc1a</italic> expression at 15 somite stage when the authors show it is expressed in the entire domain of cells expressing <italic>pax2a</italic>, or intermediate mesoderm. At this stage qRT PCR should also be performed.</p><p>– A conclusion is reached that <italic>ppargc1a</italic> is epistatic to <italic>tbx2b</italic> based on the observations that in <italic>ppargc1a</italic> deficient embryos expression of <italic>tbx2b</italic> is impaired but expression of <italic>ppargc1a</italic> is not altered in <italic>tbx2b</italic> deficient embryos. Epistatic relationships are based on combining and comparing contrasting loss or gain of function phenotypes. Whereas the two LOF phenotypes are similar, gain of <italic>tbx2b</italic> function/expression masks the loss of <italic>ppargc1a</italic>, supporting the notion that <italic>tbx2b</italic> is epistatic to <italic>ppargc1a</italic>, but <italic>ppargc1a</italic> acts upstream of <italic>tbx2b</italic>.</p><p>– Likewise, that domain of <italic>ppargc1a</italic> expression in renal progenitors was significantly increased in length, is interpreted that &quot;<italic>sim1a</italic> was probably epistatic to <italic>ppargc1a</italic>&quot;. Again these are not experiments to test epistasis. The authors do perform such experiment by creating a compound loss of function between these two genes, which have contrasting LOF phenotypes, with PST fates being lost in <italic>sim1a</italic> deficient embryos and expanded in <italic>ppargc1a</italic> mutants. And because <italic>ppargc1a;sim1a</italic> doubly deficient embryos show normal PST segment, it is <italic>ppargc1a</italic> that is epistatic to <italic>sim1a</italic>. Even though epistasis is not complete, consistent not only with <italic>pparg1a</italic> negatively regulating <italic>sim1a</italic> expression but also vice versa. The conclusions about epistatic relationships need to be revised both in the Results and Discussion sections.</p><p><italic>Reviewer #2:</italic> </p><p>The authors convincingly show that PPAR agonist treatment and genetic loss of <italic>ppargc1a</italic> result in very similar minor displacements of distal segment boundaries and that the dynamic nephric-specific expression of <italic>ppargc1</italic> correlates with a cell-autonomous role during nephron patterning. They also show that shortening of the DL segment in <italic>ppargc1</italic> mutants is associated with a shortened expression of the DL-fate determining factors <italic>tbx2b</italic> and that <italic>tbx2b</italic> RNA injection can restore DL positioning in <italic>ppargc1</italic> mutants. Further they reveal genetic evidence for cross-repressive interactions between <italic>ppargc1a</italic> and <italic>sim1</italic> in positioning the distal extension of the PST segment. The design of the experiments is clear and approaches are straightforward. However, some important questions remain unanswered and some of the results may require further analyses.</p><p>Subsection “Bioactive small molecule chemical genetic screen reveals that alteration of PPAR signaling leads to changes in embryonic nephron segmentation”: More data from the initial screen concerning 'compounds that are known to alter activity of PPAR signaling' should be provided. These data might shed some light on the somehow contradictory and currently poorly explained observations that PPAR agonist treatment and loss of <italic>ppargc1</italic> cause very similar phenotypes.</p><p>Subsection “<italic>ppargc1a</italic> is necessary for proper formation of proximal and distal segment boundaries”, last paragraph: Benzafibrate treatments restricted to the time window of <italic>ppargc1a</italic> expression (&gt;8 somite stage) rather than starting at 5hp should be used to better define the correlation between activation of PPAR signaling and <italic>ppargc1a</italic> expression/function. In case of a direct role of benzafibrate in repressing <italic>ppargc1</italic> expression it should also be possible to rescue the phenotype by <italic>ppargc1</italic> RNA-injection. Alternatively, the distal shift of <italic>ppargc1</italic> expression in benzafibrate treated embryos may be caused by an earlier patterning defect that cannot be rescued by RNA injection.</p><p>“Further, the <italic>ppargc1a</italic> signal intensity appeared…”: Quantitative analyses such as RT-qPCR should be used to confirm the suggested general reduction.</p><p>“…whether either of these changes were associated with regional fluctuations in cell birth or death.”: To answer this relevant and interesting question, it would have been necessary to study proliferation and cell death in relation to the segment/region specific markers <italic>trpm7</italic> and <italic>slc12a3</italic> rather than using the pan-nephric marker <italic>cdh17</italic>.</p><p>Subsection “<italic>ppargc1a</italic> regulates PST boundary formation through a reciprocally antagonistic relationship with the <italic>sim1a</italic> transcription factor”: The genetic cross-repressive interaction between <italic>ppargc1a</italic> and <italic>sim1a</italic> is interesting. However, to better understand the underlying molecular mechanisms it would be important to further explore whether cross-repressive interactions can be seen when using overexpression of <italic>ppargc1a</italic> and <italic>sim1a</italic> RNA. In this context the authors should also explain why embryo-wide overexpression of their RNAs appears to cause very restricted phenotypes.</p></body></sub-article><sub-article article-type="reply" id="SA2"><front-stub><article-id pub-id-type="doi">10.7554/eLife.40266.027</article-id><title-group><article-title>Author response</article-title></title-group></front-stub><body><disp-quote content-type="editor-comment"><p>Essential revisions:</p><p>Both reviewers are positive about the work, but both suggest revisions, some of which are overlapping.</p><p>1) Please use qRT-PCR to quantify the expression changes detailed in the manuscript (a suggestion of both reviewers).</p></disp-quote><p>As suggested by both of the reviewers, we have used qRT-PCR to quantify <italic>ppargc1a</italic> transcripts in response to treatment with bezafibrate, which is provided in revised Figure 2G.</p><disp-quote content-type="editor-comment"><p>2) Please revise the arguments about epistasis so that they refer to the comparison of double and single mutant phenotypes and not expression analysis in a single mutant, as suggested by reviewer 1.</p></disp-quote><p>The arguments about epistasis have been revised so that they refer to comparison of double and single mutant phenotypes.</p><disp-quote content-type="editor-comment"><p>3) Provide more data on the initial screen (reviewer 2).</p></disp-quote><p>The manuscript has been revised to provide more data on the initial screen, which is now located in Figure 1—figure supplement 1.</p><disp-quote content-type="editor-comment"><p>4) Include a more comprehensive study of cell proliferation and cell death (reviewer 2).</p></disp-quote><p>As suggested we performed comprehensive studies of cell proliferation and death at the 20 ss in the PST and DL, which are the two affected segments in <italic>ppargc1a</italic> deficient embryos, using combined fluorescent in situ hybridization and immunofluorescence techniques. We found that there was no significant difference in proliferation or death in either segment. This is consistent with the conclusion that changes in cellular turnover do not cause the PST and DL segment boundary changes that occur in <italic>ppargc1a</italic> deficient embryos.</p><disp-quote content-type="editor-comment"><p>5) Test for cross-repressive interactions by RNA overexpression (reviewer 2).</p></disp-quote><p>We performed RNA overexpression studies to assess the effect of <italic>sim1a</italic> RNA on the domain of <italic>ppargc1a</italic> expression in the kidney, and vice versa, and to evaluate the coincident development of the PST segment (Figure 5). Overexpression of <italic>sim1a</italic> was associated with a statistically significant reduction in the <italic>ppargc1a</italic> domain (Figure 5A, 5D) and an enlarged PST segment (Figure 5C, 5F). Overexpression of <italic>ppargc1a</italic> led to a statistically significant reduction in the <italic>sim1a</italic> domain (Figure 5B, 5E) at 20 ss and a shortened PST segment (Figure 5C, 5F) in addition to a decrease in the number of <italic>sim1a</italic><sup>+</sup> cells at 28 ss (Figure 5—figure supplement 2). These results with RNA overexpression provide further support for the conclusion that there are cross-repressive interactions between <italic>sim1a</italic> and <italic>ppargc1a</italic> during pronephros ontogeny.</p><disp-quote content-type="editor-comment"><p>For further information, the full reviews are appended below.</p><p>Reviewer #1:</p><p>[…]</p><p>– The conclusion that bezafibrate treatment affects ppargc1a expression is not compelling and requires further experimental analysis. Currently, expression of ppargc1a is analyzed in the drug treated embryos during late segmentation (28S – the stage is not provided on the Figure 2 or in the text) and reduced expression domain is observed. However, by this stage as shown in Figure 1, ppargc1a expression is limited to the cells that express the distal segment markers. Therefore, that ppargc1a expression domain is reduced could simply reflect that DL is reduced what is the key finding of the manuscript. The authors also note that expression level of ppargc1a RNA appears reduced, but WISH is not a quantitative method. Therefore, it would be important to analyze ppargc1a expression at 15 somite stage when the authors show it is expressed in the entire domain of cells expressing pax2a, or intermediate mesoderm. At this stage qRT PCR should also be performed.</p></disp-quote><p>We performed further experimental analyses to assess how bezafibrate treatment affects <italic>ppargc1a</italic> expression. First, we performed studies to investigate the time window of bezafibrate treatment in order to better define the correlation between activation of PPAR signaling and <italic>ppargc1a</italic> expression. Bezafibrate was added at the 4, 5, 6, 8, 9, and 10 hpf stage as well as the 5 ss and 10 ss, and embryos were incubated until the 28 ss, at which time they were fixed and <italic>ppargc1a</italic> expression was assessed by WISH (Figure 2—figure supplement 5). Bezafibrate addition at the 4, 5, 6, 8, or 9 hpf time points led to statistically significant decreases in the <italic>ppargc1a</italic> domain length compared to control embryos; further the effect of bezafibrate addition at these time points was not statistically different when compared by ANOVA (Figure 2—figure supplement 5A, B). Thus, we next added bezafibrate at the 5 hpf stage and fixed embryos at the 15 ss to analyze <italic>ppargc1a</italic> expression. Interestingly, we found no difference in <italic>ppargc1a</italic> expression between bezafibrate treated and control embryos (Figure 2—figure supplement 5C). Finally, we conducted qRT-PCR analysis on pools of embryos treated with bezafibrate or DMSO vehicle control from the 5 hpf time point until the 28 ss. Although this time window of bezafibrate exposure was associated with a reduced absolute domain length of <italic>ppargc1a</italic> expression in the pronephros (Figure 2E, 2F), the qRT-PCR analysis revealed that the relative mRNA levels were not significantly different between the groups (Figure 2E). Furthermore, we found that <italic>ppargc1a</italic> RNA overexpression was not sufficient to rescue DL development in bezafibrate treated embryos (Figure 2—figure supplement 5D, 5E). Taken together, these results are consistent with the notion that the <italic>ppargc1a</italic> expression domain is reduced in bezafibrate treated embryos because the DL is reduced, and not specifically due to the loss of <italic>ppargc1a</italic> activity. We have revised the manuscript to reflect this conclusion.</p><p>Additionally, we have addressed the reviewer’s comment about missing information in the legend to Figure 2, to clarify that the embryonic stage of the representative images is the 28 ss.</p><disp-quote content-type="editor-comment"><p>– A conclusion is reached that ppargc1a is epistatic to tbx2b based on the observations that in ppargc1a deficient embryos expression of tbx2b is impaired but expression of ppargc1a is not altered in tbx2b deficient embryos. Epistatic relationships are based on combining and comparing contrasting loss or gain of function phenotypes. Whereas the two LOF phenotypes are similar, gain of tbx2b function/expression masks the loss of ppargc1a, supporting the notion that tbx2b is epistatic to ppargc1a, but ppargc1a acts upstream of tbx2b.</p></disp-quote><p>We have revised the manuscript to correct the conclusions about epistatic relationships.</p><disp-quote content-type="editor-comment"><p>– Likewise, that domain of ppargc1a expression in renal progenitors was significantly increased in length, is interpreted that &quot;sim1a was probably epistatic to ppargc1a&quot;. Again these are not experiments to test epistasis. The authors do perform such experiment by creating a compound loss of function between these two genes, which have contrasting LOF phenotypes, with PST fates being lost in sim1a deficient embryos and expanded in ppargc1a mutants. And because ppargc1a;sim1a doubly deficient embryos show normal PST segment, it is ppargc1a that is epistatic to sim1a. Even though epistasis is not complete, consistent not only with pparg1a negatively regulating sim1a expression but also vice versa. The conclusions about epistatic relationships need to be revised both in the Results and Discussion sections.</p></disp-quote><p>We have revised the manuscript to correct the conclusions about epistatic relationships.</p><disp-quote content-type="editor-comment"><p>Reviewer #2:</p><p>[…]</p><p>Subsection “Bioactive small molecule chemical genetic screen reveals that alteration of PPAR signaling leads to changes in embryonic nephron segmentation”: More data from the initial screen concerning 'compounds that are known to alter activity of PPAR signaling' should be provided. These data might shed some light on the somehow contradictory and currently poorly explained observations that PPAR agonist treatment and loss of ppargc1 cause very similar phenotypes.</p></disp-quote><p>In the PPAR literature, other laboratories have reported both increases and decreases of <italic>ppargc1a</italic> after treatment with PPAR agonists and antagonists (Pardo et al., 2011; Liao et al., 2010; Sanoudou et al., 2010; Goto et al., 2017; Wang and Moraes, 2011). This suggests to us that different cells respond differently to PPAR pathway modulation with respect to <italic>ppargc1a/PGC1a</italic> expression.</p><p>We provide additional data from the initial screen in the revised Figure 1—figure supplement 1. Along with bezafibrate, a PPAR alpha agonist, there were 2 PPAR gamma antagonists identified as screen hits, compounds known as BADGE and GW-9662. Both PPAR gamma antagonists led to an expanded DE, and GW-9662 also led to an expanded PCT based on double WISH (for the DE marker <italic>slc12a1</italic> and the PCT marker <italic>slc20a1a</italic>). However, the screen did not directly assess either the PST or DL segments.</p><disp-quote content-type="editor-comment"><p>Subsection “ppargc1a is necessary for proper formation of proximal and distal segment boundaries”, last paragraph: Benzafibrate treatments restricted to the time window of ppargc1a expression (&gt;8 somite stage) rather than starting at 5hp should be used to better define the correlation between activation of PPAR signaling and ppargc1a expression/function. In case of a direct role of benzafibrate in repressing ppargc1 expression it should also be possible to rescue the phenotype by ppargc1 RNA-injection. Alternatively, the distal shift of ppargc1 expression in benzafibrate treated embryos may be caused by an earlier patterning defect that cannot be rescued by RNA injection.</p></disp-quote><p>Please see our response to reviewer #1, comment 1.</p><disp-quote content-type="editor-comment"><p>“Further, the ppargc1a signal intensity appeared…”: Quantitative analyses such as RT-qPCR should be used to confirm the suggested general reduction.</p></disp-quote><p>As noted above, qRT-PCR was performed to measure <italic>ppargc1a</italic> signal in bezafibrate treated embryos. We have revised the manuscript accordingly.</p><disp-quote content-type="editor-comment"><p>“…whether either of these changes were associated with regional fluctuations in cell birth or death.”: To answer this relevant and interesting question, it would have been necessary to study proliferation and cell death in relation to the segment/region specific markers trpm7 and slc12a3 rather than using the pan-nephric marker cdh17?</p></disp-quote><p>As suggested we performed cell proliferation and death immunofluorescence studies in combination with fluorescent in situ hybridization for the segment-specific markers <italic>trpm7</italic> (PST) and <italic>slc12a3</italic> (DL), which is now presented in revised Figure 3. Wild-type and <italic>ppargc1a</italic> deficient embryos had no statistically significant difference in the numbers of proliferating or dying cells in either the PST or the DL.</p><disp-quote content-type="editor-comment"><p>Subsection “ppargc1a regulates PST boundary formation through a reciprocally antagonistic relationship with the sim1a transcription factor”: The genetic cross-repressive interaction between ppargc1a and sim1a is interesting. However, to better understand the underlying molecular mechanisms it would be important to further explore whether cross-repressive interactions can be seen when using overexpression of ppargc1a and sim1a RNA. In this context the authors should also explain why embryo-wide overexpression of their RNAs appears to cause very restricted phenotypes.</p></disp-quote><p>Please see our response for Essential revisions, point #5.</p><p>Embryo-wide overexpression of these RNAs may cause restricted phenotypes because only certain tissues are competent to respond to altered levels of these transcripts. It is also possible that embryo-wide effects would be discernible at higher mRNA dosages, but the present work has not exhaustively chronicled the dosages and resultant phenotypes of each RNA through overexpression studies.</p></body></sub-article></article>